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Abstract. A straightforward synthesis of a new hybrid scorpionate ligand 
[(allyl)2B(CH2PPh2)(Pz)]  ([A2BPN] ) is reported. Coordination to rhodium resulted in square-
planar complexes [Rh(
2
-A2BPN)(L)(L’)] (L = L’= ½ cod (1,5-cyclooctadiene), CN
t
Bu, CO (6); 
L = CO, L’ = NH3, pyridine, PPh3, PMe3) for which spectroscopic data and the molecular 
structure of [Rh(
2
-A2BPN)(CO)PPh3] (11) indicate the ligand to be κN,κP-bound to rhodium 
with two dangling free allyl groups. Studies in solution point out that the six-membered 
 metallacycle undergoes a fast inversion in all of them. The bis(carbonyl) 
complex 6 easily loses a CO group to give [{Rh(A2BPN)(CO)}2], a dinuclear compound in 
which two mononuclear subunits are brought together by two bridging allyl groups. 
Coordination to iridium is dominated by a tripodal κN,κP, 2-C=C binding mode in the TBPY-5 
complexes [Ir(
3
-A2BPN)(L)(L’)] (L = L’ = ½ cod (3), CN
t
Bu (5), CO (7); L = CO, L’ = PPh3 
(13), PMe3 (14), H2C=CH2, (17), MeO2CC≡CCO2Me (dmad, 18)), as confirmed by the single-
crystal structure determination of complexes 3 and 18. A fast exchange between the two allyl 
arms is observed for complexes having L = L’ (3, 5, and 7), while those having CO and L ligands 
(14, 17 and 18) were found to be non-fluxional species. An exception is complex 13, which 
establishes an equilibrium with the SP-4 configuration. Protonation reactions on complexes 13 
and 14 with HCl yielded the hydride-complex [Ir(
2
-A2BPN)(CO)(Cl)(H)PPh3] (15) and the C-
alkyl compound  (16), respectively. 
The bis(isocyanide) complex 5 reacts with dmad to form [Ir(
2
-A2BPN)(CN
t
Bu)2(dmad)]. On the 
whole, the electronic density provided to the metal by the [A2BPN]
–
 ligand is very sensitive to 
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the coordination mode. The basicity of the new ligand is similar to that of the Tp
Me2
 ligand in the 
κN,κP mode, but comparable to Tp if coordinated in the κN,κP, 2-C=C mode. 
Introduction 
Ligand design has become a major concept in organometallic chemistry, a chemical tool 
developed to tailor the stability and/or chemical reactivity of transition metal complexes. From a 
certain perspective, the ligand architecture (described by the disposition of the donor atoms) 
mainly defines the geometry around a transition metal center in a metal complex, while the 
ligand nature (associated to the donor groups) allows for control over electronic and steric 
properties. A conjunction of both properties will eventually impact on the reactivity of their 
complexes. Consequently, an exceptional effort has been dedicated to design ligand scaffolds 
specifically to stabilize metallic fragments in a pre-defined geometry. In this context, a special 
mention is required for pincer ligands,
1
 in which the meridional coordination results in strong 
binding to the metal allowing outstanding examples of C−H bond activation.2 
Unlike the aforementioned pincer ligands, the ubiquitous poly(pyrazolyl)borate (Tp or 
scorpionate) provides three nitrogen atoms that cap one face of a coordination polyhedron.
3
 
These versatile ligands have attracted an enormous interest in distinct fields of science for a long 
time, ranging from bioinorganic chemistry to materials science, and applications in 
organometallic and coordination chemistry are very well documented.
4
 The broad body of work 
generated by these Tp-based complexes encouraged new adaptations and improvements of the 
architectures of the scorpionate ligands, mainly by varying alkyl or aryl substituents at the 3 
and/or 5 positions of the pyrazolyl rings (‘2nd generation’),5 The structural variations on these 
ligands allowed tailoring their cone and wedge angles, influencing the metal basicity by 
changing the nature of the pyrazolyl substituents, giving rise to a new set of late transition metal 
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complexes able to perform unusual metallorganic transformations.
6
 Moreover, structural 
adjustments by functionalizing the fourth site at boron (‘3rd generation’)7 has provided interesting 
examples of original oligotopic ligands to be used as scaffolds for oligonuclear complexes,
8
 and 
to covalently anchor RhTp-based systems peripherally to carbosilane dendrimers in specific 
cases.
9
 
While the catalytic properties of these N-based tripodal systems is being unfolded within the 
last years,
10
 the curiosity of scientists together with the desire for fine-tuning electronic 
parameters in tripodal assemblies led naturally to the development of non-pyrazolyl, anionic 
borate-based ligands of the type [RBD3] .
11
 These new constructs are potentially C3-symmetric 
face-capping ligands, which bear donor groups D based on atoms other than N (e.g. P,
12
 S,
13
 and 
C
14
) providing different electronic environments to the metals, which has made possible the 
observation of unusual reactivity patterns.
12d,15
 
With the idea of bringing together mixed donor sets ‘N2P’, we reported the synthesis
16
 of the 
hybrid, anionic scorpionate-like ligand [(CH2=CHCH2)B(CH2PPh2)(Pz)2]  (Pz = pyrazolate), 
while Peters and co-workers
17
 documented the related ‘P2N’ hybrid system 
[PhB(CH2P
t
Bu2)2(Pz)] . Aimed by the rich reactivity and coordination chemistry displayed by 
the iridium complexes stabilized by the ‘PN2’ tripodal system, which showed the allyl arm not to 
be innocent,
18
 we decided to take a step further in the design of such hybrid architectures and 
now we wish to report the synthesis of a new ligand with a flexible scaffold, provided with a set 
of three different donors based on hard (N) and soft (P, C) atoms of composition 
[(allyl)2B(CH2PPh2)(Pz)]  ([A2BPN] ), as well as the coordination chemistry and reactivity 
shown by its rhodium and iridium complexes. 
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Results and Discussion 
The new ligand [(allyl)2B(CH2PPh2)(Pz)]  ([A2BPN] ) features a central boron atom connected 
to two allyl groups, one pyrazolyl ring and a pendant CH2PPh2 moiety. It is a new anionic 
scorpionate if one considers that the allylic groups may coordinate to metals in a η2-C=C 
fashion.
18
 The ligand brings together hard N-donor and soft P- and C-donor groups, which makes 
the study of its coordination chemistry to transition metals very attractive, since it can 
accommodate metallic fragments in different ways. The ligand has been synthesized as the 
[Li(tmen)][A2BPN] salt ([Li(tmen)][1]) in two steps as shown in Scheme 1: i) formation of the 
intermediate [(allyl)3B(CH2PPh2)]  by treatment of B(allyl)3 with an equimolar amount of 
[Li(tmen)][CH2PPh2] ); ii) protonation of one of the allyl arms with pyrazole. This approach 
represents a convenient way to this type of system since propene is the only waste in the second 
step. Tetra-substitution of the boron atom in [A2BPN]  was confirmed by the shift of the signal at 
 –5.89 ppm, in the 11B{1H} NMR spectrum.19 A broad resonance at ‒13.6 ppm in the 31P{1H} 
NMR spectrum indicated the lithium ion to be coordinated to phosphorous, while the expected 
resonances for the equivalent allyl arms and the pyrazolyl group were observed in the 
1
H NMR 
spectrum. 
 
Scheme 1. Synthesis of compound [Li(tmen)][1].  
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Coordination of the ‘M(cod)‘ (M = Rh, Ir) fragments to 1 was achieved by reaction of 
[Li(tmen)][A2BPN] with the complexes [{M( -Cl)(cod)}2], which rendered the compounds 
[M(A2BPN)(cod)] (M = Rh, 2; Ir, 3; cod = 1,5-cyclooctadiene) as yellow and white solids, 
respectively, in good yields. Nonetheless, complex 3 was prepared in better yield starting from 
[Ir(acac)(cod)] (acac = acetylacetonate) (Scheme 2, phenyl groups on the P atom have been 
omitted for clarity in all schemes and charts). 
 
Scheme 2. Synthesis of complexes 2 and 3. i = [{Rh( -Cl)(cod)}2], ii = [Ir(acac)(cod)]. 
 
 
Both complexes were found to be fluxional and the frozen structures, shown in Scheme 2, 
were observed on cooling. At –80 ºC, both exhibited four resonances for the olefinic-cod protons 
and inequivalent allyl groups in the 
1
H NMR spectra, a clear indication of the lack of symmetry 
of the complexes. Moreover, the =CH protons from the allyl groups (marked with red and green 
circles in Scheme 2) were found as broad signals at δ 6.81 and 6.05 ppm for the rhodium 
complex 2,, i.e., in the typical region for non-coordinated olefins. Therefore, both allyl groups 
are free in 2 and the ligand binds the rhodium through the P and N ends to produce the puckered 
structure (Scheme 2) at low temperature. On the contrary, these resonances were found to be at δ 
6.45 and 3.60 ppm for the iridium counterpart (3). The shift to high-field of one of them (as well 
as for the corresponding =CH2 protons, observed at  3.92 and 2.10 ppm) agree with the bonding 
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of one of the allyl groups to iridium, which was confirmed by a single crystal X-ray analysis of 
complex 3 (see below). Consequently, the frozen structure for complex 3 corresponds to a 
pentacoordinated compound with the tripodal ligand coordinated in a κN,κP,η2-C=C fashion. 
On raising the temperature, the allyl groups coalesce in both cases, emerging as an unique allyl 
group above room temperature. For the rhodium complex 2, the set of signals was found at 
chemical shifts typical for free allyl ligands, so that an easy inversion of the six-membered 
metallacycle ( ) accounts for the experimental data (Scheme 3). This 
inversion has to occur through the planar Cs-conformation, which presents a steric hindrance 
between the olefinic-cod protons and the H
3
 proton from the pyrazolyl and the phenyl groups on 
the phosphorus. Consequently, this process should be facilitated by less demanding ligands on 
the metal centre, as shown below for the bis(carbonyl) and bis(isocyanide) derivatives. 
 
Scheme 3. Fluxional motion undergone by complex 2. 
 
 
 
On the contrary, the allyl groups of the iridium counterpart 3 emerge from the coalescence as a 
set of signals of the CH2=CH  moiety still shifted to high field (see Supporting Information). 
The equivalence of both allyl groups and the modification of chemical shifts can easily be 
interpreted as an equilibrium between two species, A and B (Scheme 4), resulting from de-
coordination of the allyl group followed by an easy boat-to-boat inversion of the square-planar 
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species and re-coordination of the other allyl group (Scheme 4). This dynamic process is 
reminiscent with that generally shown by Tp-complexes,
5d,20
 based upon sequential coordination-
decoordination steps of the pyrazolyl moieties. However, the dangling groups in the present case 
are the allylic fragments, while the pyrazolyl and phosphane arms remain coordinated throughout 
the dynamic process. Accordingly, no appreciable changes in the chemical shifts of the protons 
of the pyrazolyl group were observed in the VT-
1
H NMR spectra and the chemical shift of the 
phosphorus remained almost unaltered in the same range of temperature. 
 
Scheme 4. Proposed motions justifying the fluxional behavior of complex 3. 
 
 
 
The molecular structure of 3 together with the atom labeling scheme used is shown in Figure 1, 
while Table 1 displays selected bond distances and angles. In the complex, the iridium atom lies 
at the center of a slightly distorted trigonal bipyramid (TBPY-5) coordinated to the scorpionate 
ligand in a κN,κP, 2-C=C fashion and to the C=C bonds of cod in the typical chelating mode.  
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Figure 1. Molecular structure (ORTEP at 50 % level) of complex [Ir(
3
-A2BPN)(cod)] (3). 
Hydrogen atoms and solvent of crystallization have been removed and only the ipso carbon 
atoms of the phenyl groups are shown for clarity. 
 
Table 1. Selected bond distances (Å) and angles (º) for complex 3. 
Ir–P 2.384(2) N1–Ir−Ct3 174.1(2) 
Ir−N1 2.114(5) Ct1–Ir−Ct2 126.7(2) 
Ir–Ct1 2.143(6) P–Ir−Ct1 101.3(2) 
Ir–Ct2 2.034(6) P–Ir−Ct2 131.4(2) 
Ir–Ct3 2.095(6) N1−Ir−Ct1 86.4(2) 
C18–C19 1.385(8) N1−Ir−Ct2 90.12(2) 
C21–C22 1.345(9) N1−Ir−P 85.1(1) 
C23–C24 1.442(9) P−Ir−Ct3 97.2(2) 
C27–C28 1.403(9)   
Ct1, Ct2, and Ct3 represent the middle points of the C18 C19, C23 C24, and C27 C28 bonds, 
respectively. 
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The axial positions are occupied by the N1 atom of the pyrazolyl ring and one olefinic bond 
(C27−C28) of cod, while the P atom, the 2-C=C bond of one allyl group and the other olefinic 
bond of cod (C23–C24) lay at the equatorial sites. All the equatorial angles are different from 
each other and from 120
o
, being the P–Ir‒Ct1 angle the smallest (101.3(2)o), probably forced by 
the rigidity of the coordinate tripodal framework. The C=C bond distance of the cod ligand 
occupying the equatorial site (1.442(9) Å) is longer than that for the C=C bond at the axial site 
(1.403(9) Å), as expected from a stronger -back donation from the metal in the equatorial plane. 
For the coordinated allyl group, this C=C bond distance was even shorter (1.385(8) Å) and close 
to that in the free allyl group (1.345(9) Å), suggesting it to be a labile ligand. Noticeably, the 
2
-
allyl group was found to be bonded to iridium in a very asymmetric way, as reflected by the Ir–
C18 and Ir–C19 distances of 2.301(6) and 2.202(6) Å, respectively. On the whole, these 
distances are similar to those found in other 
2
-olefin iridium complexes such as 
[Ir(Tpm)(H)(CH=CH2)(C2H4)]PF6 (Tpm = tris(3,5-dimethylpyrazolyl)methane) (2.171(10) and 
2.142(11) Å),
21
 [IrCl(LFe)(cod)][PF6] (LFe = [Fe(
5
-C5H5){
6
-1,1-di(2-propenyl)-3-
butenyl}benzene] (2.191(6) and 2.319(6) Å),
22
 and [Ir{(Pz)B(
2
-
allyl)(CH2PPh2)(Pz)}(CO)PMe3] (2.227(4) and 2.168(5) Å).
18
 
Related isocyanide and carbonyl complexes of formula [M(A2BPN)(L)2] (L = CN
t
Bu, M = Rh, 
4; Ir, 5; L = CO, M = Rh, 6; Ir, 7) were easily prepared by reacting complexes 2 and 3 with 
CN
t
Bu in a 1:2 molar ratio, and by bubbling carbon monoxide through solutions of 2 and 3. The 
bis(isocyanide) complexes 4 and 5 were stable enough to be isolated as yellow and white solids, 
respectively. However, the bis(carbonyl) derivatives 6 and 7 were maintained as such only under 
an atmosphere of carbon monoxide and, consequently, they were characterized in situ. In fact, 
evaporation of the solvent was associated to the loss of one carbonyl ligand from the rhodium 
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complex (to give the dimer [{Rh(A2BPN)(CO)}2] (8), see below) and a full decomposition for 
the iridium compound.  
Complexes 4-7 retain the original stereochemistry of their cod precursors (2, 3), which 
depends on the metal: while rhodium tends to adopt square-planar geometries, iridium prefers 
TBPY-5 environments facilitated by the 
2
-C=C coordination of one allyl group. Accordingly, 
equivalent free allyl groups were observed in the 
1
H NMR of the rhodium complexes (4 and 6) at 
room temperature, as commented above for [Rh(
2
-A2BPN)(cod)] (2) (See Experimental 
Section). On cooling, no changes in the spectra were observed, which indicates a lower energy 
barrier for the inversion of the metallacycle than for the cod complexes. This lower barrier can 
be expected from the lesser steric requirements of the isocyanide and carbonyl ligands relative to 
cod, which lead to less hindered planar conformations, as observed in related dinuclear puckered 
structures.
23
 In addition, two intense bands at 2159 and 2114 cm
–1
, assigned to the symmetric and 
antisymmetric stretches of the isocyanide ligands, were observed in the IR spectrum of 4. These 
frequencies compare well with those shown by [Rh(Tp
Me2
)(CNR)2] (R = neopentyl, xylyl, Me), 
in which a 
2
N coordination of the Tp
Me2
 ligand was confirmed both in solution and in the solid 
state.
24
 However, the nature of complex 4 differs drastically from that of the Tp complex 
[{RhTp}2(µ-CNCy)3], which is stabilized by three isocyanide bridging moieties.
25
 
On the other hand, variable temperature NMR spectra of the iridium counterparts (5 and 7) 
indicated both to be penta-coordinated species at low temperature, but undergo a fast allyl-
exchange at room temperature. As a way of example, Figure 2 shows the 
1
H NMR spectra 
corresponding to the low and fast exchange region for the iridium isocyanide complex 5.  
 12 
 
Figure 2. 
1
H NMR spectra of complex [Ir(
3
-A2BPN)(CN
t
Bu)2] (5) in d8-toluene, showing the 
two inequivalent allyl groups at ‒50 ºC (bottom) and their fast exchange a r.t. (top). 
  
The electron density at the metal provided by the new A2BPN ligand can be deduced from the 
(CO) stretchings, which faithfully reflect such event. SP-4 [Rh(
2
-A2BPN)(CO)2] (6) shows 
two intense (CO) absoptions at 2083 and 2020 cm
–1
 (cyclohexane), similar to that reported for 
[Rh(
2
-Tp
Me2
)(CO)2] (2080, 2012 cm
–1
 in pentane),
26
 while that for TBPY-5 [Ir(
3
-
A2BPN)(CO)2] (2053, 1982 cm
–1
, cyclohexane) were found to be closer to that for [Ir(
3
-
Tp)(CO)2] (2051, 1971 cm
–1
 in acetonitrile) than for [Ir(
3
-Tp
Me2
)(CO)2] (2035, 1954 cm
–1
 in 
toluene).
27
 Therefore, the electronic density delivered by A2BPN to the metal seems to be similar 
to that of the Tp
Me2
 ligand in the κN,κP mode, but comparable to Tp if coordinated in the 
κN,κP, 2-C=C mode. 
As indicated above, attempts to isolate [Rh(
2
-A2BPN)(CO)2] (6) led to the loss of one 
carbonyl ligand with crystallization of the product as the dimer [{Rh(A2BPN)(CO)}2] (8). Figure 
3 shows the molecular structure of 8 and selected bond lengths and angles are summarized in 
Table 2. Complex 8 consists of two mononuclear subunits brought together by two bridging allyl 
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groups coordinated in a -η2-C=C fashion, forming in this way a twelve-membered 
dimetallacycle. In each metallic subunit, the rhodium atom lies in the center of a slightly 
distorted square-planar environment with the scorpionate ligand coordinated to the metal through 
the N and P atoms in a chelating fashion. The CO group is located trans to N and the fourth 
coordination site is occupied by the C=C double bond of the allyl group from the other metallic 
subunit. In this geometry, the carbonyl and allyl groups having the greatest trans influence
28
 are 
mutually cis, while the good -donor pyrazolyl group is opposite the strongest  acceptor 
(CO).
29
 
 
Figure 3. Molecular structure (ORTEP at 50 % level) of complex [{Rh(A2BPN)(CO)}2] (8). 
Hydrogen atoms have been removed and only the ipso carbon atoms of the phenyl groups are 
shown for clarity. 
 
The Rh–C(olefin) bond distances (2.305 Ǻ in average) were found to be considerably longer 
than those found for some Rh(I)-ethylene complexes. For comparison, average Rh–C distances 
of 2.097, 2.125, and 2.206 Ǻ were observed for square-planar complexes of the type 
[RhX(L)2(C2H4)],
30
 [Rh(L2)(C2H4)2],
31
 and [Rh(mer-L3)(C2H4)]
n+
,
32
 respectively. Furthermore, 
the C18–C19 (1.367(7) Ǻ) and C41–C42 (1.382(7) Ǻ) bond distances are only slightly longer 
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than those observed for the uncoordinated allyl groups (C21–C22, 1.312(7) Ǻ; C44–C45, 
1.326(7) Ǻ), which indicates it to be a labile ligand with weak -back donation from the metal to 
the olefin. In good agreement, the signals of the coordinated CH2=CH  moiety were only 
slightly shifted upfield (4.91 ppm in average) when compared to the uncoordinated one (5.57 
ppm in average) in the 
1
H NMR spectrum. 
 
Table 2. Selected bond distances (Å) and angles (º) for complex 8. 
Rh1–P1 2.2864(14) Rh2–P2 2.2905(14) 
Rh1–N1 2.098(4) Rh2–N3 2.108(4) 
Rh1–C41  2.291(5) Rh2–C18 2.349(4) 
Rh1–C42  2.286(5) Rh2–C19  2.294(4) 
Rh1–Ct2 2.182(5) Rh2–Ct1 2.219(4) 
Rh1−C23 1.813(6) Rh2−C46 1.819(6) 
C18–C19 1.367(7) C41–C42 1.382(7) 
C21–C22 1.312(7) C44–C45 1.326(7) 
N1–Rh1–C23 176.3(2) N3–Rh2–C46 175.1(2) 
P1–Rh1–Ct2 177.6(2) P2–Rh2–Ct1 171.4(2) 
Ct1 and Ct2 represent the middle point of C18 and C19, and C41 and C42, respectively. 
 
P- and N-donor ligands cleave the dinuclear unit in 8 to generate the square-planar carbonyl 
complexes [Rh(
2
-A2BPN)(CO)L] (L = pyridine (py), 9; NH3, 10; PPh3, 11; PMe3, 12). 
Complexes 9, 11, and 12 were isolated as yellow solids in good yields, but the formation of the 
NH3 compound 10 was found to be reversible; working-up only led to the recovery of the 
starting material. It was, however, completely characterized in solution, since its synthesis was 
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quantitative (NMR evidence, See Experimental Section). The κN,κP-coordination of the ligand 
to rhodium in these complexes was definitively confirmed from an X-ray study on complex 11, 
whose molecular structure is shown in Figure 4. Selected bond distances and angles are given in 
Table 3. 
 
Figure 4. Molecular structure (ORTEP at 50 % level) of complex [Rh(
2
-A2BPN)(CO)PPh3] 
(11). Hydrogen atoms have been removed and only the ipso carbon atoms of the phenyl groups 
are shown for clarity. 
 
Table 3. Selected bond distances (Å) and angles (º) for complex 11. 
Rh–P1 2.3042(9) P1–Rh–P2 176.88(3) 
Rh–P2 2.3313(9) N1–Rh–C23 175.42(12) 
Rh–N1  2.096(3) N1–Rh–P1 87.20(7) 
Rh–C23 1.811(3) P2–Rh–C23 87.41(10) 
C18–C19 1.313(4)   
C21–C22 1.322(5)   
 
In the complex, the square-planar rhodium atom is bound to the nitrogen of the pyrazolyl and 
the phosphorus atoms of the scorpionate ligand, a carbonyl group, and the phosphorus atom from 
PPh3. Both phosphane donors are placed mutually trans, while the pyrazolyl group remains trans 
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to the strongest  acceptor (CO) as observed for 8. The six-membered metallacycle (
) shows the expected puckered conformation, which minimizes the steric 
repulsion between the H
3
 proton from the pyrazolyl and the phenyl groups of PPh3. The terminal 
CO ligands in 9-12 were located cis to the phosphane arm of the ligand (JC,P = 12-17 Hz), while 
both allyl groups were found to be non-coordinated to rhodium (
1
H NMR evidence), information 
that confirms that they are square-planar complexes with the ligand in the bidentate N, P 
coordination mode (Chart 1). Moreover, as found for 11 in the solid state, both phosphane groups 
in 11 and 12 showed a mutual trans disposition as deduced from the large JP
A
,P
B values of 297 
and 309 Hz, respectively. Furthermore, the (CO) stretching (toluene/C6D6) of complexes 9-12 
(1977, 1972, 1981, and 1977 cm
1
, respectively) reflects a weak influence of the basicity of the 
ligands (pyridine, NH3, PMe3, and PPh3, respectively) on the electronic density of the metal. 
 
Chart 1. Stereochemistry of complexes 9-14.  
 
 
The iridium counterparts [Ir(
3
-A2BPN)(CO)PR3] (R = Ph, 13; Me, 14) were isolated as white 
solids in good yields by treating the bis-carbonyl complex 7 with the corresponding phosphanes. 
Both complexes displayed the typical features for pentacoordinated species (with an allyl bonded 
to iridium) in their 
1
H and 
13
C{
1
H} NMR spectra at low temperature, while they showed a single 
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(CO) band in their solid state IR spectra. However, it was very surprising the divergence in 
values of this stretching, 2008 cm‒
1 
for the PPh3 complex 13 and 1920 cm
‒1 for the PMe3 
analogue 14, a difference too large (88 cm‒
1
) to be explained by considering only the basicity of 
the phosphane ligands. Moreover, the JP
A
,P
B coupling constants in the 
31
P{
1
H} NMR spectra at 
low temperature (45 Hz for 13 and 12 Hz for 14) suggest a coupling of the type 
2
JPeq,Peq for the 
former while 
2
JPeq,Pax for the later.
33, 34
 Consequently, complexes 13 and 14 differ in their 
stereochemistry. Thus, the axial location of the CO ligand in 13 accounts for the high (CO) 
stretching, while the low frequency for 14 is consistent with the binding of this ligand in an 
equatorial position. In fact, theoretical studies on pentacoordinated d
8
-complexes
35
 predict a 
strong metal–ligand -interaction in the equatorial position, so that lower v(CO) frequencies can 
be expected for CO(eq) when compared to those for CO(ax) in similar complexes. Moreover, a 
survey of the reported v(CO) frequencies in TBPY-5 iridium complexes of general formula 
[IrR(CO)(olefin)P2]
36
 and related ones containing fac-tripodal ligands of the type [Ir(
3
-
L3)(CO)(olefin)]
37
 agree with this consideration. Hence, we propose a TBPY-5-34_COax 
configuration for 13 and TBPY-5-31_COeq for 14 (Chart 1) to account for the spectroscopic data. 
Further support from this proposal comes from DFT studies carried out on the two possible 
TBPY-5 isomers of 13 and 14. The TBPY-5-34_COax configuration for [Ir(
3
-A2BPN)(CO)PPh3] 
(13) was found to be 4.8 kcal mol‒
1
 more stable ( G) than the TBPY-5-31_COeq, which was 
found to be samewhat distorted due to the steric hindrance of the close phosphane groups (Figure 
5). On the contrary, the configuration with the CO ligand in the equatorial plane was found to be 
2.5 kcal mol‒
1
 more stable than that with an axial carbonyl in [Ir(
3
-A2BPN)(CO)PMe3] (14). 
Moreover, the observed (CO) stretching frequencies fit nicely with the DFT calculated ones for 
the proposed structures (Table 4). 
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Figure 5. DFT optimized (b3-lyp, TZVP) geometries of [Ir(
3
-A2BPN)(CO)PPh3] (13) in 
different configurations: TBPY-5-34_COax isomer (left) and TBPY-5-31_COeq (right). Code 
color: Ir (green), N (blue), P (pink), B (orange) and O (red). P−Ir−P angles (º): 115.7 and 101.6 
for TBPY-5-34_COax and TBPY-5-31_COeq, respectively. 
 
Table 4. Experimental and DFT calculated (CO) stretching frequencies for 13 and 14. 
[Ir(A2BPN)(CO)PPh3] (13) [Ir(
3
-A2BPN)(CO)PMe3] (14) 
solid toluene TBPY-5-34 SP-4 TBPY-5-31 solid toluene TBPY-5-34 TBPY-5-31 
2008 2000, 
1978 
2004 1971 1938 1920 1928 1992 1935 
Calculated DFT-frequencies have been corrected by a factor of 0.996.  
 
For the TBPY-5 configurations, the better -acceptor ligands are expected to be found at the 
equatorial positions. Complex [Ir(
3
-A2BPN)(CO)PMe3] (14) follows this general trend, since 
the CO and C=C groups lie at equatorial sites. However, steric effects can reverse this trend, as 
shown for [Ir(
3
-A2BPN)(CO)PPh3] (13), in which the CO ligand is located at the axial site to 
minimize the steric hindrance provided by the bulky phenyl groups. This effect is expected to 
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reach a maximum in a square-planar configuration (Chart 1), since both P-ligands separate from 
120 to 180º. The NMR spectra at room temperature of 13 features equivalent free allyl groups 
and a coupling constant JP
A
,P
B = 194 Hz, close to the expected value for a square-planar trans 
stereochemistry (ca. 300 Hz). Therefore, a fast equilibrium between pentacoordinated (13a) and 
square-planar (13b) geometries (Chart 1) accounts for the NMR data at room temperature. Such 
equilibrium can be ascribed to the steric pressure exerted by the bulky PPh3 ligand, which would 
facilitate the dissociation of the allyl arm. The VT-NMR spectroscopic data were analyzed with a 
Van ’t Hoff plot, which provided the following thermodynamic parameters associated with the 
equilibrium 13a  13b: ΔH° = +2.7 ± 0.1 kcal mol−1 and ΔS° = +9.3 ± 0.5 cal mol−1 K−1, which 
results in ΔG°293.15 = −0.045 kcal mol
−1
. In good agreement, values of +3.28 kcal mol
−1
 (ΔH°) 
and ‒ 0.20 kcal mol−1 (ΔG°293.15) were obtained from DFT calculations (see supporting 
information). 
Moreover, both isomers were detected by IR spectroscopy in solution by two broad (CO) 
bands at 2000 (m) and 1978 (s) cm‒
1
, corresponding to the minor TBPY-5-34_COax and the major 
square-planar isomers, respectively. Again, the frequency of the (CO) band for the trans 
square-planar isomer (SP-4) matchs satisfactorily with that found by DFT-calculations (Table 4).  
On the other hand, complex [Ir(
3
-A2BPN)(CO)PMe3] (14) was found to be the sole isomer 
with a TBPY-5-31_COeq configuration at room temperature, according to the NMR and IR 
spectra (see Experimental Section), and hence electronic issues dominates the stereochemistry in 
this case.  
The different structure of the main isomers of 13 and 14 is largely responsible for the reactivity 
pattern observed in their reactions of protonation. Both complexes reacted readily with dry HCl 
in a 1:1 molar ratio affording the Ir(III) complexes [Ir(
2
-A2BPN)(CO)(Cl)(H)PPh3] (15) and 
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 (16) respectively, which were 
isolated as white solids in good yields (Scheme 5). 
 
Scheme 5. Protonation reactions of 13 and 14 leading to complexes 15 and 16. 
 
Characterization of complex 15 was achieved by a combination of the usual spectroscopic and 
analytical methods, which allowed to detect the phosphane groups mutually trans, and the 
hydrido (at  = –14.47) and CO ligands cis to both P atoms and mutually cis to each other (See 
Experimental Section). These data indicated that complex 15 is octahedral with the scorpionate 
ligand adopting a P, N coordination mode and the other four sites occupied by PPh3, CO, the 
hydride and a chloride ligand, a chemical composition confirmed by MALDI spectrometry. 
Moreover, the shift to higher frequency of the (CO) band, at 2058 cm
−1
, is in accordance with a 
decrease of the electron density on the metal or an Ir(III) oxidation state in 15. 
Protonation of PMe3 complex 14 with hydrogen chloride followed a different profile and 
afforded the neutral complex 16, which did not show hydrido signals in the 
1
H NMR spectrum. 
Instead, there was a new set of resonances that corresponded to a -bonded ‘–CH(Me)CH2B’ 
moiety. The spectroscopic data collected for 16 unambiguously pointed out to the octahedral 
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structure shown in Scheme 5, which features a new hydrocarbyl arm -bonded to iridium (see 
Experimental Section for details). The (CO) band observed at 2061 cm
−1
 confirmed the 
oxidation of the metal to Ir(III) in the reaction. Complex 16 showed a static 
1
H NMR spectrum 
with several features to be noticed. One of the allyl arms is uncoordinated, while a different set 
of resonances were deduced to correspond to the new hydrocarbyl fragment arising formally 
from a Markovnikov addition of the proton to the C=C bond of the other allyl fragment. The low 
coupling constant JP
A
,P
B = 22 Hz indicated a mutual cis disposition of both phosphanes. In 
addition, two well differentiated coupling constants were observed for the terminal CO (JC,P  = 
132 and 9 Hz) in the 
13
C{
1
H} NMR spectrum, which located CO cis to PMe3 and trans to the 
phosphane arm due to the fac imposed coordination of the scorpionate ligand. In this way, NMR 
data of complex 16 reflect accurately the structure and stereochemistry also found for the closely 
related compound [Ir{(Hpz)B(CH2CHCH3)(CH2PPh2)(Pz)}(Cl)(CO)PMe3]Cl.
18
 
Structural comparison between the Ir(III) complexes 15 and 16 reveals information about the 
mechanisms following protonation of 13 and 14 with HCl. The square-planar isomer of 13 is 
favored for a direct protonation at the iridium centre (Figure 6, left) from the external face to 
give the square pyramidal intermediate with the coordination vacancy trans to the hydride 
ligand. Then, a fast inversion of the metallacycle places the hydride ligand inside the pocket of 
the complex allowing the coordination of the chloride again at the less hindered external face to 
give the product from a trans oxidative-addition of HCl (Scheme 6).
38
 
Scheme 6. Proposed mechanism for the protonation of complex 13. 
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Regarding the protonation of the PMe3 compound 14, a similar path would require the 
previous decoordination of the allyl arm, a dynamic process that was not observed by NMR. 
Nonetheless, complex 14 shows a HOMO mainly formed by the dx
2
-y
2
 orbital of the iridium  
atom backdonating to both, the * orbital of rhe C=C group and the * orbital of the C=O ligand 
(Figure 6). 
 
Figure 6. HOMO of SQ-4-[Ir(
2
-A2BPN)(CO)PPh3] (13, left) and two views of the HOMO of 
TBPY-5-31_COeq -[Ir(
3
-A2BPN)(CO)PMe3] (14). The red arrow indicates the external face of 
the complex while that in blue indicates the H2C= carbon from the coordinated allyl arm. 
Consequently, a direct Markovnikov addition of the proton to the H2C= carbon (marked with 
the blue arrow in Figure 6) seems to be the most probable initial step, although the protonation of 
the metal followed by insertion of the coplanar olefin into the Ir H bond cannot be fully 
excluded. A further binding of the chloride at the coordination vacancy (trans to the alkyl group) 
would give the protonation product 16 (Scheme 7). 
Scheme 7. Proposed mechanism for the protonation of complex 14. 
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Related complexes of formula [Ir(
3
-A2BPN)(CO)L] (L= H2C=CH2, 17; MeO2CC≡CCO2Me, 
18) were prepared by reacting the bis(carbonyl) compound 7 with ethylene or 
MeO2CC≡CCO2Me (dmad), respectively (Chart 2). The ethylene complex 17 was found to be 
static at room temperature (i.e. no ethylene rotation around the Ir C2H4 axis takes place on the 
NMR time scale), which agrees with a 
2
-(C=C) coordination coplanar with the equatorial plane 
of a trigonal bipyramidal arrangement. As a matter of fact, 
1
H-
1
H NOESY experiments 
corroborated the ethylene ligand to be in the equatorial site of the TBPY-5 geometry, since the 
olefinic protons located upwards the equatorial plane (marked with red circles) gave a strong 
NOE effect with the H
3
 proton of the pyrazolyl arm (Chart 2). Accordingly, the ν(CO) stretching 
(C6D6) at 2013 cm
−1
 fits quite well to that expected for a carbonyl ligand at the axial site, as 
observed for complex 13.
39
 Since steric arguments can be ruled out because of the small size of 
the ethylene ligand, we can conclude that the TBPY-5-23_COax configuration represents the most 
stable isomer on the basis of electronic issues as observed for related complexes.
39
 
Chart 2. Stereochemistry of complexes 17-18.  
 
Concerning the complex [Ir(
3
-A2BPN)(CO)(dmad)] (18), in which ethylene is formally 
replaced by a dimethyl acetylenedicarboxylate ligand in 17, spectroscopic data indicated both to 
be similar, as confirmed by a X-ray difraction study for 18. Figure 7 shows the ORTEP 
representation of the molecule and Table 5 collects selected bond lengths and angles. The 
iridium center in 18 has a distorted trigonal bipyramidal environment with the pyrazolyl and the 
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CO ligands occupying the axial sites, while the equatorial plane is defined by the phosphane arm, 
the 
2
-bonded allyl fragment and the π-bonded acetylene with its initial triple bond 
asymmetrically bound and lying in the equatorial plane.  
 
Figure 7. Molecular structure (ORTEP at 50 % level) of complex [Ir(
3
-A2BPN)(CO)(dmad)] 
(18). Hydrogen atoms and solvent of crystallization have been removed and only the ipso carbon 
atoms of the phenyl groups are shown for clarity. 
 
The length of the acetylenic C26‒C27 linkage expands from ca. 1.20 to 1.246(9) Å upon 
coordination, and possesses a cis-bent configuration associated with angles at the acetylenic 
carbons of C25‒C26‒C27 = 147.3(7)o and C26‒C27‒C28 = 147.7(7)o, comparable to those 
found in other dmad iridium complexes such as [Ir(COCH2CMe3)(P(p-tolyl)3)(dmad)]
39
 and 
[IrMe(CO)(PPh3)2(dmad)].
40
 
Table 5. Selected bond distances (Å) and angles (º) for complex 18. 
Ir–P 2.3543(19) N1–Ir−C23 179.2(3) 
Ir−N1 2.097(6) Ct1–Ir−Ct2 133.7(3) 
Ir–Ct1 2.164(7) P–Ir−Ct1 102.2 (2) 
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Ir–Ct2 2.019(7) P–Ir−Ct2 123.5(2) 
Ir–C23 1.856(7) N1−Ir−Ct1 88.6(2) 
C18–C19 1.383(9) N1−Ir−Ct2 87.5(2) 
C21–C22 1.326(10) N1−Ir−P 86.9(2) 
C26−C27 1.246(9)   
Ct1, and Ct2 represent the middle point of C18 and C19, and C27 and C28, respectively. 
 
Spectroscopic data in solution for complex 18 (
1
H, 
31
P{
1
H}, 
13
C{
1
H} NMR and IR spectra) are 
consistent with the pentacoordinated structure found in the solid state. In particular, the chemical 
shifts for the Csp atoms of the coordinated alkyne (  91.5 and 86.9 ppm) compare well with those 
found in the structurally related complex [Ir(Tp
Me2
)(CO)(dmad)] (86.2 ppm),
41
 while the quite 
different coupling constants JC,P of 7 and 40 Hz, respectively, reflect a C27‒Ir‒P angle 
(106.3(2)º) more closed than the related C26‒Ir‒P angle (140.4(2)º). The distinct coupling 
constants also confirm the lack of rotation of the acetylene around the Ir‒C≡C axis, since 
otherwise similar averaged coupling constants would be observed. The better -aceptor character 
of dmad respect to ethylene is clearly observable from blue-shift of the ν(CO) stretching in the 
IR spectra from 2013 (17) to 2040 cm
−1
 (18). 
The isoelectronic isocyanide compound [Ir(
3
-A2BPN)(CN
t
Bu)2] (5) reacted with dmad in a 
different way keeping the isocyanide ligands to afford the complex [Ir(
2
-
A2BPN)(CN
t
Bu)2(dmad)] (19) in good yields. Moreover, two inequivalent non-coordinated 
allylic arms were clearly observable in the 
1
H and 
13
C{
1
H} NMR spectra of 19. In addition, the 
coordinated dmad showed coupling constants JC,P of 6 and 66 Hz, the later suggesting an angle 
C‒Ir‒P bigger than 140º, which is intermediate between octahedral (OC-6) and TBPY-5 
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geometries around iridium. Furthermore, the IR stretching frequencies of the isocyanide ligands 
in complex 19 are shifted ca. 116 cm
-1
 to higher frequencies relative to 5.  
Most probably, the different reactivity involving the addition of dmad to complexes  [Ir(
3
-
A2BPN)(L)2] (L = CN
t
Bu, 5; CO, 7) could be ascribed to the stronger bonding of the isocyanide 
to iridium. In fact, complex [Ir(
3
-A2BPN)(CO)(dmad)] (18) is even formed in the presence of a 
carbon monoxide atmosphere. 
 
Conclusion 
Summarizing, we report the straightforward synthesis of a novel hybrid scorpionate ligand 
[(allyl)2B(CH2PPh2)(Pz)]
–
, which is equipped with different donors, including hard N and soft P 
and C atoms. We have disclosed the coordination behaviour of this ligand system, which has 
proven to be highly versatile in stabilizing rhodium and iridium metallic complexes in a number 
of different coordination modes. The Rh(I) complexes are square-planar, with the ligand 
coordinated in a bidentate N, P fashion, although in a specific example (i.e the dinuclear 
carbonyl complex [{Rh(A2BPN)(CO)}2]) the ligand adopts the unexpected N, P, -
2
-(C=C) 
coordination mode. A general behaviour observed for these rhodium complexes is the dynamic 
fast inversion of the six-membered metallacycle ( ).  
The Ir(I) complexes described herein tend to adopt pentacoordinated TBPY-5 geometries with 
one allyl arm coordinated, i.e. the ligand adopts a N, P,
2
-(C=C) coordination mode. The 
lability of the Ir-allyl interaction and the flexibility of the ligand architecture lead to distinct 
behavior in solution. Thus, complexes with symmetrical or equivalent ancillary ligands like 
[Ir(
3
-A2BPN)(cod)] (3) and [Ir(
3
-A2BPN)(L)2] (L = CN
t
Bu, 5; CO, 7) adopt TBPY-5 structures 
at low temperature, but undergo a fast allyl-exchange based on a sequential coordination and de-
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coordination of both allyl groups on heating. On the contrary, this allyl-exchange was not 
observed for complexes with two different ligands like [Ir(
3
-A2BPN)(CO)L] (L = PMe3, 14; 
CH2=CH2, 17; MeO2CC≡CCO2Me, 18), indicative of the electronic preference of the more -
accepting ligand for the equatorial position (CO in 14, and the alkene/alkyne in 17 and 18). An 
exception was [Ir(
3
-A2BPN)(CO)PPh3] (13) for which steric effects dominate: i) placing the CO 
at the axial site and ii) producing a fast equilibrium with the less hindered square-planar isomer. 
The Ir(I)-TBPY-5 complexes having the CO ligand at the axial site led to, at a first glance, a 
‘counterintuitive’ high ν(CO) stretching frecuencies, even higher than those expected for square-
planar configurations. Nonetheless, the weak -back retrodonation from the metal to the CO 
ligand at the axial site accounts for the data, as proven from some DFT-calculations on selected 
examples, which result in a nice fitting between experimental and calculated ν(CO) frequencies.  
The phosphane compounds [Ir(
3
-A2BPN)(CO)PR3] are basic enough to be protonated by HCl, 
in a reaction drived by the stereochemistry of the starting complexes. Direct protonation of 
iridium occurs for the square-planar PPh3 isomer (13), but a direct attack of the proton to the 
H2C= carbon in TBPY-5 PMe3 compound (14) seem to be the most probable pathways for the 
syntesis of [Ir(
2
-A2BPN)(CO)(Cl)(H)PPh3] (15) and 
 (16), respectively. The stronger 
bonding to iridium of isocyanides when compared to the carbonyl ligands is probably the origin 
of the different reactivity of complexes [Ir(
3
-A2BPN)(L)2] (L = CN
t
Bu, 5; CO, 7) towards 
dmad, which results in complexes [Ir(
2
-A2BPN)(CO)(dmad)] (18) and  [Ir(
2
-
A2BPN)(CN
t
Bu)2(dmad)] (19), respectively. 
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Experimental Section. 
Starting Materials and Physical Methods. All the operations were carried out under an argon 
atmosphere using standard Schlenk techniques. Solvents were dried and distilled under argon 
before use by standard methods.
42
 Complexes [{Rh( -Cl)(cod)}2],
43
 [{Ir( -Cl)(cod)}2]
44
 and 
[Ir(acac)(cod)],
45
 and compounds [Li(tmen)][CH2PPh2]
46
 and [B(CH2CH=CH2)3]
47
 were 
prepared according to literature procedures. All the other chemicals used in this work have been 
purchased from Aldrich Chemicals and used as received. Carbon, hydrogen and nitrogen 
analyses were carried out with a Perkin-Elmer 2400 CHNS/O microanalyzer. FAB mass spectra 
were recorded in a VG Autospec double-focusing mass spectrometer. The ions were produced by 
the standard Cs
+
 gun at ca. 30 kV; 3-nitrobenzyl alcohol (NBA) was used as matrix. Electrospray 
mass spectra (ESI-MS) were recorded in methanol on a Bruker MicroTof-Q using sodium 
formiate as reference. MALDI-Tof mass spectra were obtained on a Bruker Microflex mass 
spectrometer using DCTB (trans-2-[3-(4-tert-butylphenyl)-2-methyl-2-
propenylidene]malononitrile) or dithranol as matrix. NMR spectra were recorded on Bruker AV 
300 and AV 400 spectrometers operating at 300.13 and 400.13 MHz, respectively, for 
1
H. 
Chemical shifts are reported in ppm and referenced to SiMe4, using the internal signal of the 
deuterated solvent as reference (
1
H, 
13
C) and external H3PO4 (
31
P). IR spectra in solution were 
recorded with a Nicolet 550 spectrophotometer using NaCl cells, while IR spectra of solid 
samples were recorded with a Perkin-Elmer 100 FT-IR Spectrometer (4000-400 cm
-1
) equipped 
with an ATR (Attenuated Total Reflectance). 
Synthesis of the compounds: [Li(tmen)][A2BPN]  (1). Tris(allyl)borane (1.31 g, 1.70 mL, 
9.80 mmol) was slowly added for 10 min via syringe to a bright yellow suspension of 
[Li(tmen)][CH2PPh2] (3.17 g. 9.83 mmol) in toluene (15 mL) at room temperature. The color of 
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the mixture gradually discharged to form a milky suspension, which was stirred for 40 min. 
Addition of a solution of pyrazole (0.68 g, 9.80 mmol) in toluene (15 mL) to the reaction mixture 
via cannula resulted in the precipitation of a white solid, which was dissolved upon heating at 
50
o 
C for one hour to give a clear colorless solution. The reaction mixture was evaporated to 
dryness under vacuum leaving a white oily residue that was washed with cold hexanes to afford a 
white solid, which was vacuum-dried. Yield: 3.07 g (65 %). Anal. Calcd (%) for C28H41BLiN4P 
(482.39): C 69.71, H 8.57, N 11.61; found: C 69.62, H 8.49, N 11.56. 
1
H NMR (300 MHz, C6D6, 
25 ºC): δ 8.10 (s, 1H, pz), 7.34 (m, 4H, Ho PPh2), 7.14 (m, 7H, H
m+p
 PPh2 + pz), 6.41 (s, 1H, pz), 
6.32 (m, 2H, =CH), 5.16 (m, 4H, =CH2), 1.95 (d, J = 7.8 Hz, 4H, CH2-allyl), 1.80 (s, 12H, CH3-
tmen), 1.72 (m, 6H, CH2-tmen + CH2P). 
31
P{
1
H} NMR (121 MHz, C6D6, 25 ºC): δ ‒13.6 (br s). 
13
C{
1
H} NMR (75 MHz, C6D6, 25 ºC): δ 144.3 (=CH-allyl), 137.6 (pz), 133.5 (pz), 132.5 (d, JC,P 
= 15 Hz, C
o
 PPh2), 128.4‒127.3 (PPh2), 109.8 (=CH2-allyl), 102.7 (pz), 56.6 (CH2-tmen), 45.6 
(CH3-tmen), 33.9 (br s, CH2-allyl), 22.7 (br, CH2P). 
11
B{
1
H} NMR (96 MHz, C6D6, 25 ºC): δ 
‒5.89 (s). MS (MALDI-TOF+): m/z (%):439.1 (40) [M‒allyl‒H]+.  
[Rh(
2
-A2BPN)(cod)] (2). Solid [{Rh( -Cl)(cod)}2] (0.37 g, 0.75 mmol) was added to a 
solution of 1 (0.72 g, 1.49 mmol) in toluene (10 mL). The mixture was stirred for 30 min to give 
a yellow cloudy suspension, which was filtered via cannula through a pad of celite under argon 
to afford a clean yellow solution. Evaporation of the solvent under vacuum gave an oily material, 
which was triturated with pentane to yield a yellow solid that was subsequently filtered and then 
vacuum-dried. Yield: 0.77 g (91 %). Anal. Calcd (%) for C30H37BN2PRh (570.33): C 63.18, H 
6.54, N 4.91; found: C 63.08, H 6.49, N 4.87. 
1
H NMR (300 MHz, C6D6, 25 ºC): δ 7.63 (m, 4H, 
H
o
 PPh2), 7.59 (d, J = 1.7 Hz, 1H, pz), 7.26 (d, J = 1.8 Hz, 1H, pz), 7.07 (m, 6H, H
m+p
 PPh2), 
6.36 (m, 2H, =CH-allyl), 5.97 (t, J = 2.1 Hz, 1H, pz), 5.43 (dd, J = 17.0, 2.9 Hz, 2H) and 5.28 
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(dd, J = 10.1, 3.0 Hz, 2H) (=CH2-allyl), 4.99 (m, 2H) and 3.40 (m, 2H) (=CH-cod), 2.93 (m, 2H, 
CH2-cod), 2.39 (m, 4H, CH2-allyl), 2.35 (m, 2H) and 1.79 (m, 4H) (CH2-cod), 1.68 (d, JH,P = 
14.3 Hz, 2H, CH2P). 
1
H NMR (400 MHz, d
8
-toluene, ‒ 80 ºC): selected resonances δ 7.44 (br, 
1H, pz), 7.03(br s, 1H, pz), 6.81 (br m, 1H) and 6.05 (br m, 1H) (=CH-allyl), 5.88 (br, 1H, pz), 
5.58 (br m, 2H) and 5.40 (br d, J = 9.9 Hz, 2H), 4.86 (br, 1H), 4.61 (br, 1H), 3.47 (br, 1H) and 
2.80 (br, 1H) (=CH-cod). The remaining signals were found to be too much broad for 
unequivocal assignment. 
31
P{
1
H} NMR (121 MHz, C6D6, 25 ºC): δ 29.1 (d, JP,Rh = 144 Hz). 
13
C{
1
H} NMR (75 MHz, C6D6, 25 ºC): δ 143.3 (=CH-allyl), 138.5 (pz), 135.8 (d, JC,P = 39 Hz, 
C
i
 PPh2), 134.9 (pz), 133.0 (d, JC,P = 10 Hz, C
o
 PPh2), 129.2 (d, JC,P = 2 Hz, C
m
 PPh2), 127.9 (C
p
 
PPh2), 110.6 (=CH2-allyl), 104.5 (pz), 101.1 (dd, JC,P = 13 Hz, JC,Rh = 11 Hz) and 72.5 (d, JC,Rh = 
12 Hz) (=CH-cod), 35.0 (br, CH2-allyl), 32.4 and 28.8 (CH2-cod), 19.8 (br, CH2P). MS 
(MALDI-TOF
+
): m/z (%):529.2 (100) [M‒allyl]+. 
[Ir(
3
-A2BPN)(cod)] (3). Solid [Ir(acac)(cod)] (0.20 g, 0.50 mmol) was added to a white 
suspension of 1 (0.24 g, 0.50 mmol) in diethyl ether (10 mL). The mixture was stirred for 30 min 
to form a suspension, which was filtered via cannula through a pad of celite under argon to 
afford a clean pale-orange solution. Evaporation of the solvent under vacuum gave an orange 
solid, which was recrystallized from dichloromethane-hexane. Yield: 0.27 g (81 %). Starting 
from [{Ir( -Cl)(cod)}2]: To a white suspension of 1 (0.13 g, 0.28 mmol) in toluene (10 mL) solid 
[{Ir( -Cl)(cod)}2 (0.09 g, 0.14 mmol ) was added. The mixture was stirred for 1 hour and passed 
through a pad of cellite to remove the solid. The resulting solution was evaporated to dryness and 
the resulting orange oil was treated with cold hexanes to afford an orange solid, which was then 
filtered out and dried by vacuum. Yield: 0.12g (68%). Anal. Calcd (%) for C30H37BIrN2P 
(659.64): C 54.63, H 5.65, N 4.25; found: C 54.59, H 5.59, N 4.18. 
1
H NMR (400 MHz, d8-
 31 
toluene, 100 ºC): δ 7.59 (br s, 1H, pz), 7.41 (m, 4H, PPh2), 7.08 (m, 6H, PPh2), 6.70 (br s, 1H) 
and 5.82 (br s, 1H) (pz), 4.94 (br s, 2H, =CH-allyl), 4.49 (d, J = 9.5 Hz, 2H) and 3.74 (d, J = 14.3 
Hz, 2H) (=CH2-allyl), 3.4-2.4 (flat, 4H, =CH-cod), 2.12 (m, 4H, CH2-cod), 1.72 (br m, 4H, CH2-
cod), 1.63 (br m, 4H, CH2-allyl), 1.15 (J = 12.6 Hz, 2H, CH2P). 
1
H NMR (400 MHz, d8-toluene, 
‒80 ºC): δ 7.61 (br, 1H, pz), 7.27 (m, 2H, Ho PPh2), 7.14 (m, 3H, H
m+p
 PPh2), 7.08 (m, 2H, H
m
 
PPh2), 6.99 (m, 1H, H
p
 PPh2), 6.95 (m, 2H, H
o
 PPh2), 6.61 (br, 1H, pz), 6.45 (m, 1H, =CH-allyl), 
5.87 (br, 1H, pz), 5.31 (d, J = 16.9 Hz, 1H) and 5.21 (d, J = 16.9 Hz, 1H) (=CH2-allyl), 3.92 (d, J 
= 4.9 Hz, 1H, =CH2-
2
-allyl), 3.70 (s, 1H, =CH-cod), 3,60 (m, 2H, =CH-cod + =CH-
2
-allyl), 
2.91 (s, 1H, =CH-cod), 2.25 (m, 2H, CH2-cod), 2.10 (m, 2H, =CH2-
2
-allyl + CH2-
2
-allyl), 1.97 
(m, 2H, CH2-allyl), 1.88 (m, 1H, CH2-cod), 1.72 (m, 1H, CH2-
2
-allyl, 1.64 (m, 1H, CH2P), 1.60 
(m, 2H, CH2-cod + =CH-cod), 1.56 (m, 1H, CH2-cod), 1.37 (m, 1H), 1.09 (m, 2H, CH2 cod), 
0.73 (m, 1H, CH2P). 
31
P{
1
H} NMR (161 MHz, C6D6, 25 ºC): δ 1.6. 
13
C{
1
H} NMR (100 MHz, 
d8-toluene, –80 ºC): δ 143.6 (=CH-allyl), 142.6 (d, JP,C = 35 Hz) and 138.8 (d, JP,C = 40 Hz) (C
i
 
PPh2), 134.9 and 133.6 (pz), 133.4 (d, JP,C = 8 Hz, C
o
 PPh2), 130.8 (d, JP,C = 9 Hz, C
m
 PPh2), 
129.6 (C
p
 PPh2), 128.3 (m, C
o+m+p
 PPh2), 110.9 (=CH2-allyl), 104.5 (pz), 75.1, 70.7 and 64.9 (d, 
JP,C = 6 Hz) (=CH-cod),  63.1 (d, JP,C = 7 Hz, =CH-
2
-allyl), 58.8 (d, JP,C = 21 Hz, =CH-cod), 
47.3 (d, JP,C = 8 Hz, =CH2-
2
-allyl), 35.2 (br m, CH2-allyl), 34.8 (br m, CH2-
2
-allyl), 31.9, 31.4, 
30.6, and 30.4 (CH2-cod), 20.2 (br m, CH2P). 
11
B{
1
H} NMR (96 MHz, CDCl3, 25 ºC): δ 0.55 (br 
s). MS (MALDI-TOF
+
): m/z (%): 619.1 (100) [M‒allyl]+. 
[Rh(
2
-A2BPN)(CN
t
Bu)2] (4). To a yellow solution of 2 (0.12 g, 0.21 mmol) in diethyl ether 
(10 mL), CN
t
Bu (39 mg, 53 µl, 0.47 mmol) was slowly added via syringe and the resulting 
mixture was stirred for 30 min at room temperature. The solution was concentrated under 
vacuum to ca. 2 mL and a further addition of hexanes gave a light orange oil. This was 
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redissolved in diethyl ether and further addition of hexanes afforded a yellow powder which was 
isolated by filtration and then vacuum-dried. Yield: 0.11 g (86 %). Anal. Calcd (%) for 
C32H43BN4PRh (628.41): C 61.16, H 6.90, N 8.92; found: C 61.09, H 6.80, N 8.81. IR (toluene): 
ν(CN)/cm−1: 2159 (s), 2114 (s). 1H NMR (300 MHz, C6D6, 25 ºC): δ 7.91 (m, 4H, H
o
 PPh2 + 1H 
,pz), 7.80 (d, J = 1.8 Hz, 1H, pz), 7.09 (m, 6H, H
m+p
 PPh2), 6.39 (m, 2H, =CH-allyl), 6.14 (t, J = 
2.1 Hz, 1H, pz), 5.22 (dd, J = 16.8, 3.3 Hz, 2H) and 5.08 (dd, J = 12.6, 3.3 Hz, 2H) (=CH2-allyl), 
2.86 (m, 2H) and 2.13 (m, 2H) (CH2-allyl), 1.58 (d, JH,P = 13.2 Hz, 2H, CH2P), 1.99 (s, 9H) and 
0.86 (s, 9H) (CN
t
Bu). 
31
P{
1
H} NMR (121 MHz, C6D6, 25 ºC): δ 28.2 (d, JP,Rh = 130 Hz). 
13
C{
1
H} NMR (75 MHz, C6D6, 25 ºC): δ 144.0 (=CH-allyl), 142.5 (pz), 139.9 (d, JC,P = 39 Hz, 
C
i
 PPh2), 134.0 (pz), 133.5 (d, JC,P = 12 Hz, C
o
 PPh2), 128.5 (d, JC,P = 2 Hz, C
m
 PPh2), 127.7 (C
p
 
PPh2), 109.5 (=CH2-allyl), 103.4 (pz), 55.9 and 55.6 (CMe3), 35.1 (br, CH2-allyl), 30.0 and 29.8 
(CMe3), 20.6 (br s, CH2P). MS (MALDI-TOF
+
): m/z (%): 586.2 (10) [M‒allyl]+. 
[Ir(
3
-A2BPN)(CN
t
Bu)2] (5). To a solution of 3 (0.10 g, 0.15 mmol) in dietyl ether (7 mL), 
CN
t
Bu (39 µl, 0.34 mmol) was added dropwise via syringe. The colour of the solution changed 
rapidly to orange and 20 minutes after the reaction mixture was evaporated to dryness affording 
an orange oily residue. Addition of cold hexanes gave a white solid, which was filtered off and 
then dried under vacuum. Yield: 0.094 g (87%). Anal. Calcd (%) for C32H43BIrN4P (717.72): C 
53.55, H 6.04, N 7.81; found: C 53.48, H 5.95, N 7.67. IR (toluene): ν(CN)/cm−1: 2085 (s), 2043 
(s). 
1
H NMR (300 MHz, d8-toluene, ‒50 ºC): δ 8.05 (s, 1H, pz), 7.74 (m, 2H) and 7.63 (m, 2H) 
(H
o
 PPh2), 7.43 (s, 1H, pz), 7.00 (m, 6H, H
m+p
 PPh2), 6.88 (m, 1H, =CH-allyl), 6.03 (s, 1H, pz), 
5.53 (d, J = 17.0 Hz, 1H) and 5.45 (d, J = 12.0 Hz, 1H) (=CH2-allyl), 3.26 (m, 1H, =CH2), 3.10 
(m, 1H, =CH) and (m, 1H, =CH2 + 1H, CH2) (
2
-allyl), 2.22 (m, 2H, CH2-allyl + 1H, CH2P), 
1.31 (m, 1H, CH2-
2
-allyl +1H, CH2P), 1.01 (s, 9H) and 0.46 (s, 9H) (CN
t
Bu). 
31
P{
1
H} NMR 
 33 
(121 MHz, d8-toluene, 25 ºC): δ 0.0. 
13
C{
1
H} NMR (75 MHz, d8-toluene, −50 ºC): δ 144.6 
(=CH-allyl), 142.7 (d, JP,C = 36 Hz) and 141.6 (d, JC,P = 25 Hz) (CN
t
Bu), 141.1 (pz), 137.3 (d, 
JC,P = 43 Hz ) and 137.3 (d, JC,P = 49 Hz) (C
i
 PPh2), 133.7 (d, JC,P = 13 Hz, C
o
 PPh2), 131.4 (pz), 
131.1 (d, JC,P = 10 Hz, C
o
 PPh2), 128 (m, C
m+p
 PPh2), 110.4 (=CH2-allyl), 105.0 (pz), 56.1 and 
55.9 (CMe3), 40.0 (d, JP,C = 6 Hz, =CH-
2
-allyl), 35.2 (br, CH2-allyl), 30.9 (d, JP,C = 25 Hz, 
=CH2-
2
-allyl) , 30.2 and 29.9 (CMe3), 24.9 (br, CH2-
2
-allyl), 21.4 (br, CH2P). MS (MALDI-
TOF
+
): m/z (%): 719.2 (5) [M‒H]+, 677.2 (100) [M‒allyl]+. 
[Rh(
2
-A2BPN)(CO)2] (6). A solution of 2 (0.02 g, 0.03 mmol) in d8-toluene (0.4 mL) was 
shaken with carbon monoxide for 10 min to give a clear yellow solution. NMR monitoring of the 
sample showed a clean and quantitative conversion to 6. IR (toluene): ν(CO)/cm−1: 2077 (s), 
2018 (s); (cyclohexane) ν(CO)/cm−1: 2083 (s), 2020 (s). 1H NMR (300 MHz, d8-toluene, ‒50 
ºC): δ 7.38 (dd, J = 6.7, 3.1 Hz, 2H, Ho PPh2), 7.35 (d, J = 2.2 Hz, 1H, pz), 7.32 (dd, J = 6.2, 3.1 
Hz, 2H, H
o
 PPh2), 7.14 (br, 1H, pz), 6.90 (m, 6H, H
m+p
 PPh2), 6.11 (ddd, J = 17.3, 14.9, 7.1 Hz, 
2H, =CH-allyl), 5.74 (t, J = 2.2 Hz, 1H, pz), 5.00 (br, 2H) and 4.96 (m, 2H) (=CH2-allyl), 2.28 
(dd, J = 12.2, 7.7 Hz, 2H) and 1.78 (dd, J = 12.0, 8.4 Hz, 2H) (CH2-allyl), 1.50 (d, JH,P = 14.9 
Hz, 2H, CH2P). 
31
P{
1
H} NMR (121 MHz, d8-toluene, 25 ºC): δ 30.9 (d, JP,Rh = 120 Hz). 
13
C{
1
H} 
NMR (75 MHz, d8-toluene, ‒50 ºC): δ 189.0 (br) and 185.4 (d, JC,Rh = 66 Hz) (CO), 142.9 (=CH-
allyl), 141.8 (pz), 135.8 (d, J = 45 Hz, C
i
 PPh2), 134.7 (pz), 132.4 (d, J = 11 Hz, C
o
 PPh2), 130.0 
(d, J = 2 Hz, C
p
 PPh2), 128.5 (d, J = 10 Hz, C
m
 PPh2), 105.3 (=CH2-allyl), 104.5 (pz), 34.3 (br, 
CH2-allyl), 19.1 (br, CH2P). MS (MALDI-TOF
+
): m/z (%): 517.3 (2) [M‒H]+. 
[Ir(
3
-A2BPN)(CO)2] (7) was prepared as described for 6 starting from a solution of 3 (0.03 g, 
0.05 mmol) in CD2Cl2 (0.4 mL). IR (diethyl ether): ν(CO)/cm
−1
: 2053 (s), 1986 (s); 
(cyclohexane) ν(CO)/cm−1: 2053 (s), 1982 (s). 1H NMR (300 MHz, CD2Cl2, ‒55 ºC): δ 7.57 (s, 
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1H, pz), 7.51-7.34 (m, 10H, PPh2), 7.22 (s, 1H, pz), 6.04 (m, 1H, =CH-allyl), 5.96 (s, 1H, pz), 
4.84 (d, J = 17.4 Hz, 1H) and 4.77 (d, J = 10.0 Hz, 1H) (=CH2 allyl), 3.56 (m, 1H, =CH), 3.35 
(m, 1H, =CH2) and 1.96 (m, 1H, =CH2) (
2
-allyl), 1.62 (m, 1H, CH2P), 1.60 (m, 1H, CH2-allyl), 
1.57 (m, 1H, CH2-
2
-allyl), 1.44 (m, 1H, CH2-allyl), 1.35 (m, 1H, CH2P), 0.20 (m, 1H, CH2-
2
-
allyl). 
31
P{
1
H} NMR (121 MHz, CD2Cl2, 25 ºC): δ −0.6. 
13
C{
1
H} NMR (75 MHz, CD2Cl2, ‒55 
ºC): δ 184.6 (d, JC,P = 17 Hz) and 166.8 (d, JC,P = 5 Hz) (CO), 143.8 (pz), 143.1 (=CH-allyl), 
137.6 (d, JC,P = 43 Hz) and 135.4 (d, JC,P = 43 Hz) (C
i
 PPh2), 132.8 (pz), 132.4 (d, JC,P = 12 Hz) 
and 130.4 (d, JC,P = 11 Hz) (C
o
 PPh2), 128.5 (m, C
m+p
 PPh2), 110.7 (=CH2-allyl), 106.1 (pz), 53.8 
(br, =CH-
2
-allyl), 36.6 (d, JC,P = 16 Hz, =CH2-
2
-allyl), 33.9 (br, CH2-allyl), 24.4 (br, CH2-
2
-
allyl), 16.8 (br, CH2P). MS (MALDI-TOF
+
): m/z (%): 607.1 (100) [M]
+
. 
[{Rh(A2BPN)(CO)}2] (8). A solution of 2 (0.15 g, 0.26 mmol) in diethyl ether (20 mL) was 
bubbled with carbon monoxide for 30 min to give an orange solution. The volume of the reaction 
mixture was reduced to ca. 5 mL under vacuum and then hexanes were added slowly to facilitate 
the precipitation of a bright yellow solid, which was filtered, washed with cold hexanes and then 
dried under vacuum. Yield: 0.11 g (85%). Anal. Calcd (%) for C46H50B2N4O2P2Rh2 (908.31): C 
56.36, H 5.14, N 5.72; found: C 56.28, H 5.02, N 5.68. IR (toluene): ν(CO)/cm−1: 1995 (s). 1H 
NMR (300 MHz, C6D6, 25 ºC): δ 7.55 (m, 8H, H
o
 PPh2), 7.32 (d, J = 2.3 Hz, 2H, pz), 6.91 (m, 
12H, H
m+p
 PPh2), 6.71 (d, J = 1.9 Hz, 2H, pz), 6.33 (dq, J = 17.2, 8.3 Hz, 2H, =CH-allyl), 5.60 (t, 
J = 2.5 Hz, 2H, pz), 5.24 (dd, J = 16.9, 2.9 Hz, 2H) and 5.13 (dd, J = 10.0, 2.8 Hz, 2H) (=CH2-
allyl), 4.98 (br, 2H, =CH-
2
-allyl + 2H, =CH2-
2
-allyl), 4.77 (d, J = 11.0 Hz, 2H, CH2-
2
-allyl), 
4.45 (d, J = 5.6 Hz, 2H, =CH2-
2
-allyl), 2.09 (t, J = 10.5 Hz, 2H, CH2-
2
-allyl), 1.95 (m, 2H) 
and 1.84 (m, 2H) (CH2-allyl), 1.72 (t, J = 15.2 Hz, 2H) and 1.57 (t, J = 13.7 Hz, 2H) (CH2P). 
31
P{
1
H} NMR (121 MHz, C6D6, 25 ºC): δ 30.6 (d, JP-Rh = 150 Hz). 
13
C{
1
H} NMR (75 MHz, 
 35 
C6D6, 25 ºC): δ 192.1 (dd, JC,Rh = 71 Hz,
 
JC,P = 14 Hz, CO), 142.1 (=CH-allyl), 138.7 (dd, JC,P = 
46, 3 Hz, C
i
 PPh2) 138.4 (pz), 135.0 (d, JC,P = 48 Hz, C
i
 PPh2), 134.8 (pz), 133.5 (d, JC,P = 11 Hz) 
and 131.5 (d, JC,P = 11 Hz) (C
o
 PPh2), 129.6 (d, JC,P = 2 Hz) and 129.2 (d, JC,P = 2 Hz) (C
p
 PPh2), 
128.3 (d, JC,P = 10 Hz) and 128.1 (d, JC,P = 10 Hz) (C
m
 PPh2), 126.7 (dd, JC,Rh = 18 Hz, JC,P = 7 
Hz, =CH-
2
-allyl), 111.4 (=CH2-allyl), 105.2 (pz), 79.8 (dd, JC,Rh = 12 Hz, JC,P = 6 Hz, =CH2-
2
-
allyl), 45.7 (br s, CH2-
2
-allyl), 31.7 (CH2-allyl), 21.5 (br, CH2P). MALDI(+): m/z 840 (M
+
-
allyl-CO).   
[Rh(
2
-A2BPN)(CO)py] (9). To a yellow solution of 8 (0.12 g, 0.13 mmol) in dietyl ether (6 
mL), pyridine (21 mg, 21 µL, 0.26 mmol) was added via syringe. After 1 hour of stirring a 
brown solid was formed, which was filtered out, washed with cold hexanes and vacuum-dried. 
Yield: 0.13 g (88%). Anal. Calcd (%) for C28H30BN3OPRh (569.25): C 59.08, H 5.31, N 7.38; 
found: C 59.13, H 5.28, N 7.25. IR (ATR): ν(CO)/cm−1: 1967 (s); IR (toluene): ν(CO)/cm−1: 
1977 (s). 
1
H NMR (300 MHz, C6D6, 25 ºC): δ 8.36 (s, 1H, py), 7.91 (m, 4H, H
o
 PPh2), 7.76 (d, J 
= 3.0 Hz, 1H, pz), 7.27 (s, 1H, py), 7.14 (m, 6H, H
m+p
 PPh2 + 1H, py), 6.71 (d, J = 3.0 Hz, 1H, 
pz), 6.38 (m, 2H, =CH-allyl), 6.35 (s, 1H, py), 6.32 (s, 1H, py), 5.87 (t, J = 3.0 Hz, 1H, pz), 5.36 
(d, J = 17.1 Hz, 2H) and 5.25 (d, J = 9.9 Hz, 2H) (=CH2-allyl), 2.85 (m, 2H) and 2.36 (m, 2H) 
(CH2-allyl), 1.95 (d, JH,P = 15.0 Hz, 2H, CH2P). 
31
P{
1
H} NMR (121 MHz, C6D6, 25 ºC): δ 41.7 
(d, JP,Rh = 145 Hz). 
13
C{
1
H} NMR (100 MHz, C6D6, 25 ºC): δ 191.0 (dd, JC,Rh = 56 Hz, JC,P = 13 
Hz, CO), 151.4 (py), 142.3 (=CH-allyl), 138.0 (pz), 137.4 (d, JC,P = 36 Hz, C
i
 PPh2), 135.9 (py), 
133.6 (pz), 131.7 (d, JC,P = 10 Hz, C
o
 PPh2), 128.1 (py), 126.2–128.5 (C
m+p
 PPh2 + py), 123.4 
(py), 109.5 (=CH2-allyl), 102.7 (pz), 33.8 (br, CH2-allyl), 19.4 (br, CH2P). MS (MALDI-TOF
+
): 
m/z (%): 529.3 (90) [M‒allyl]+, 491.3 (70) [M‒py]+. 
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[Rh(
2
-A2BPN)(CO)NH3] (10). A solution of 8 (0.02 g, 0.02 mmol) in C6D6 (0.5 mL) was 
shaken with gaseous ammonia leading to a colourless solution within five minutes. Inspection of 
the NMR spectra revealed a clean and quantitative conversion to complex 10. IR (C6D6): 
ν(CO)/cm−1: 1972 (s). 1H NMR (300 MHz, C6D6, 25 ºC): δ 7.81 (m, 4H, H
o
 PPh2), 7.71 (s, 1H, 
pz), 7.12 (m, 6H, H
m+p
 PPh2), 6.81 (s, 1H, pz), 6.31 (m, 2H, =CH-allyl), 5.96 (s, 1H, pz), 5.22 (d, 
J = 15.6 Hz, 2H) and 5.14 (d, J = 10.2 Hz, 2H) (=CH2-allyl), 2.73 (m, 2H) and 2.25 (m, 2H) 
(CH2-allyl), 1.83 (d, JH,P = 15.0 Hz, 2H, CH2P), ‒0.03 (free and coordinated NH3). 
31
P{
1
H} 
NMR (121 MHz, C6D6, 25 ºC): δ 42.0 (d, JP,Rh = 150 Hz). 
13
C{
1
H} NMR (75 MHz, C6D6, 25 
ºC): δ 192.3 (dd, JC,Rh = 74 Hz,
 
JC,P = 17 Hz, CO), 143.6 (=CH-allyl), 138.7 (d, JC,P = 47 Hz, C
i
 
PPh2), 137.9 and 134.6 (pz), 132.7 (d, JC,P = 11 Hz, C
o
 PPh2), 129.1 (d, JC,P = 2 Hz, C
p
 PPh2), 
127.9 (d, JC,P = 10 Hz, C
m
 PPh2), 110.1 (=CH2-allyl), 104.1 (pz), 34.9 (br, CH2-allyl), 20.7 (br, 
CH2P). MS (MALDI-TOF
+
): m/z (%): 478.1 (80) [M‒CO]+.  
[Rh(
2
-A2BPN)(CO)PPh3] (11). To a solution of 8 (0.15 g, 0.17 mmol) in diethyl ether (7 
mL), solid triphenylphosphane (0.089 g, 0.34 mmol) was added and the resulting yellow mixture 
was stirred for 30 min. Evaporation of the solvent under vacuum to ca. 2 ml and slow addition of 
hexanes (7 ml) caused the precipitation of an orange solid, which was filtered, washed with cold 
hexanes and then vacuum-dried. Yield: 0.13 g (88%). Anal. Calcd (%) for C41H40BN2OP2Rh 
(752.44): C 65.45, H 5.36, N 3.72; found: C 65.15, H 5.15, N 3.92. IR (ATR): ν(CO)/cm−1: 1976 
(s), IR (toluene): ν(CO)/cm−1: 1981 (s). 1H NMR (300 MHz, C6D6, 25 ºC): δ 7.24 (m, 10H, H
o
 
PPh2 + PPh3), 6.87 (s, 1H, pz), 6.69 (m, 15H, H
m+p
 PPh2 + PPh3), 6.29 (d, J = 3.0 Hz, 1H, pz), 
6.08 (m, 2H, =CH-allyl), 5.17 (t, J = 2.2 Hz, 1H, pz), 5.02 (dd, J = 17.0, 3.0 Hz, 2H) and 4.86 
(dd, J = 10.0, 3.0 Hz, 2H) (=CH2-allyl), 2.13 (m, 4H, CH2-allyl), 1.58 (d, JH,P = 11.7 Hz, 2H, 
CH2P). 
31
P{
1
H} NMR (121 MHz, C6D6, 25 ºC): ABX spin system (X = 
103
Rh) δPA = 31.6, δPB = 
 37 
30.0, JP
A
,P
B = 297 Hz, JP
A
,Rh = 122 Hz, JP
B
,Rh = 125 Hz). 
13
C{
1
H} (75 MHz, C6D6, 25 ºC): δ 192.9 
(ddd, JC,Rh = 71 Hz,
 
JP,C = 16, 12 Hz, CO), 143.6 (=CH-allyl), 140.9 (pz), 137.2 (dd, JC,P = 40, 12 
Hz, C
i
 PPh3), 135.2 (pz), 134.4 (d, JC,P = 11 Hz, C
o
 PPh2), 133.9 (dd, JC,P = 39, 9 Hz, C
i
 PPh3), 
132.6 (dd, JC,P = 10 Hz, C
o
 PPh2), 130.3 (C
p
 PPh3), 129.2 (C
p
 PPh2), 128.5 (d, JC,P = 8 Hz, C
m
 
PPh3), 127.9 (d, JC,P = 8 Hz, C
m
 PPh2), 110.8 (=CH2-allyl), 104.1 (pz), 35.5 (br, CH2-allyl), 19.4 
(br, CH2P). MS (MALDI-TOF
+
): m/z (%): 711.0 (30) [M‒allyl]+.  
[Rh(
2
-A2BPN)(CO)PMe3] (12). A solution of 8 (0.10 g, 0.11 mmol) in toluene (10 mL) was 
treated with trimethylphosphane (16 mg, 23 L, 0.22 mmol) via syringe and the resulting yellow 
mixture was stirred for 15 min. Evaporation of the solvent under vacuum to ca. 5 mL and slow 
addition of hexanes (10 mL) caused the precipitation of a yellow solid, which was filtered, 
washed with cold hexanes and then vacuum-dried. Yield: 0.10 g (95%). Anal. Calcd (%) for 
C26H34BN2OP2Rh (566.23): C 55.15, H 6.05, N 4.95; found: C 55.05, H 6.10, N 4.92. IR (ATR): 
ν(CO)/cm−1: 1970 (s), IR (toluene): ν(CO)/cm−1: 1977 (s). 1H NMR (300 MHz, C6D6, 25 ºC): δ 
7.71 (m, 4H, H
o
 PPh2 + 1H, pz), 7.10 (m, 6H, H
m+p
 PPh2 + 1H, pz), 6.32 (m, 2H, =CH-allyl), 
5.93 (t, J = 2.1 Hz, 1H, pz), 5.39 (dd, J = 17.1, 3.0 Hz, 2H) and 5.24 (dd, J = 9.9, 3.0 Hz, 2H) 
(=CH2-allyl), 2.62 (m, 2H,) and 2.30 (m, 2H) (CH2-allyl), 1.85 (d, JH,P = 13.2 Hz, 2H, CH2P), 
1.00 (d, JH,P = 10.5 Hz, 9H, PMe3). 
31
P{
1
H} NMR (121 MHz, C6D6, 25 ºC): δ 28.8 (dd, JP,P = 
309 Hz, JP,Rh = 116 Hz), −12.6 (dd, JP,P = 309 Hz, JP,Rh = 121 Hz). 
13
C{
1
H} NMR (75 MHz, 
C6D6, 25 ºC): δ 193.1 (ddd, JC,Rh = 69 Hz,
 
JC,P = 15, 12 Hz, CO), 143.5 (=CH-allyl), 140.0 (pz), 
137.1 (d, JC,P = 41 Hz, C
i
 PPh2), 134.7 (pz), 132.4 (d, JC,P = 11 Hz, C
o
 PPh2), 129.1 (C
p
 PPh2), 
127.9 (d, JC,P = 9 Hz, C
m
 PPh2), 110.1 (=CH2-allyl), 104.1 (pz), 34.6 (br, CH2-allyl), 19.8 (br, 
CH2P), 17.0 (d, JC,P = 26 Hz, PMe3). MS (MALDI-TOF
+
): m/z (%): 525.2 (85) [M‒allyl]+, 539.2 
(20) [M‒CO]+. 
 38 
[Ir(
3
-A2BPN)(CO)PPh3] (13). A suspension of 3 (0.44 g, 0.66 mmol) in diethyl ether (20 
mL) was bubbled with carbon monoxide to give a bright yellow solution in 30 min. The addition 
of triphenylphosphane (0.17 g, 0.66 mmol) to this solution caused the discharge of the color 
within seconds. After 20 minutes, evaporation of the solvent under vacuum gave an orange oil, 
that was washed with cold hexanes to yield a pale yellow solid, which was filtered and then 
vacuum-dried. Yield: 0.49 g (88%). Anal. Calcd (%) for C41H40BIrN2OP2 (841.76): C 58.50, H 
4.79, N 3.33; found: C 58.74, H 4.93, N 3.29. IR (ATR): ν(CO)/cm−1: 2008 (s), IR (toluene): 
ν(CO)/cm−1: 2000 (m), 1978 (s). 1H NMR (300 MHz, d8-toluene, 25 ºC): δ 7.61 (m, 10H, H
o
 
PPh2 + PPh3), 7.54 (d, J = 2.0 Hz, 1H, pz), 7.06 (m, 15H, H
m+p
 PPh2 + PPh3), 6.77 (d, J = 1.8 Hz, 
1H, pz), 5.92 (m, 2H, =CH-allyl), 5.53 (d, J = 2.1 Hz, 1H, pz), 4.82 (d, J = 9.9 Hz, 2H) and 4.67 
(d, J = 15.9 Hz, 2H) (=CH2-allyl), 2.31 (m, 2H) and 2.05 (m, 2H) (CH2-allyl), 2.02 (d, 
2
JH,P = 
12.0 Hz, 2H, CH2P). 
31
P{
1
H} NMR (121 MHz, d8-toluene, 25 ºC): AB spin system δPA = 17.7, 
δPB = 11.1, JPA,PB = 194 Hz).
1
H NMR (300 MHz, d8-toluene, −80 ºC): δ 7.69 (br, 1H, pz), 7.32 
(m, 4H, H
o
 PPh2), 6.93 (m, 6H, H
m+p
 PPh2 + 15H, PPh3), 6.78 (m, 1H, =CH-allyl), 6.69 (br, 1H, 
pz), 5.56 (d, J = 15.9 Hz, 1H) and 5.50 (d, J = 12.5 Hz, 1H) (=CH2-allyl), 5.52 (s, 1H, pz), 3.79 
(br, 1H, =CH-
2
-allyl), 3.28 (br, 1H, =CH2-
2
-allyl), 2.32 (br, 1H) and 2.22 (br, 1H) (CH2-allyl), 
2.14 (br, 1H, =CH-
2
-allyl), 0,98 (m, 1H, CH2-
2
-allyl + 2H, CH2P), 0.78 (br, 1H, CH2-
2
-allyl). 
31
P{
1
H} NMR (121 MHz, d8-toluene, −70 ºC): AB spin system δPA = 3.1, δPB = −8.3, JPA,PB = 45 
Hz). 
13
C{
1
H} NMR (75 MHz, CDCl3, 25 ºC) δ 175.7 (t, JC,P = 10 Hz, CO), 142.5 (pz), 142.4 (d, 
JC,P = 7 Hz, =CH-allyl), 138.0 (d, JC,P = 41 Hz, C
i
 PPh3), 134.3 (pz), 134.2 (d, JC,P = 12 Hz, C
o
 
PPh3), 133.7 (dd, JC,P = 43 Hz, C
i
 PPh2), 132.2 (d, JC,P = 11 Hz, C
o
 PPh2), 130.0 (d, JC,P = 2 Hz, 
C
p
 PPh3), 128.9 (d, JC,P = 2 Hz, C
p
 PPh2), 128.2 (d, JC,P = 10 Hz, C
m
 PPh3), 127.7 (d, JC,P = 10 
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Hz, C
m
 PPh2), 115.0 (=CH2-allyl), 104.2 (pz), 29.7 (br, CH2-allyl), 28.0 (br, CH2P). MS 
(MALDI-TOF
+
): m/z (%): 801.1 (100) [M‒allyl]+. 
[Ir(
3
-A2BPN)(CO)PMe3] (14). A solution of 7 (0.33 g, 0.50 mmol) in diethyl ether (20 mL) 
was bubbled with carbon monoxide giving in 30 min a bright yellow solution. The addition of 
trimethylphosphane (37 mg, 51 L, 0.50 mmol) to this solution caused the discharge of the color 
to form a white solution within 1 min and then a white solid began to crystallize out after 5 min 
of stirring. The solid was collected by filtration, washed with cold hexanes and then vacuum-
dried. Yield: 0.27 g (98%). Anal. Calcd (%) for C26H34BIrN2OP2 (655.55): C 47.64, H 5.23, N 
4.27; found: C 47.35, H 5.19, N 4.11. IR (ATR): ν(CO)/cm−1: 1920 (s), IR (toluene): 
ν(CO)/cm−1: 1928 (s). 1H NMR (300 MHz, C6D6, 25 ºC): δ 7.96 (d, J = 2.0 Hz, 1H, pz), 7.93 (m, 
2H) and 7.45 (m, 2H) (H
o+o‘
 PPh2), 7.43 (d, J = 2.1 Hz, 1H, pz), 7.23 (td, J = 6.7, 1.1 Hz, 2H, H
m
 
PPh2), 7.05 (td, J = 7.0, 1.1 Hz, 1H, H
p
 PPh2), 7.00 (m, 3H, H
m‘+p‘
 PPh2), 6.63 (m, 1H, =CH-
allyl), 5.89 (t, J = 2.1 Hz, 1H, pz), 5.36 (dd, J = 16.8, 3.0 Hz, 1H) and 5.28 (dd, J = 10.2, 3.0 Hz, 
1H) (=CH2-allyl), 2.93 (m, 1H, =CH-
2
-allyl), 2.82 (m, 1H) and 2.47 (m, 1H) (=CH2-
2
-allyl), 
2.17 (m, 1H, CH2-
2
-allyl), 2.04 (m, 2H, CH2-allyl + 1H, CH2P), 1.34 (t, JH,H = JH,P = 13.6 Hz, 
1H, CH2P), 1.10 (m, 1H, CH2-
2
-allyl), 0.58 (d, JH,P = 10.5 Hz, 9H, PMe3). 
31
P{
1
H} NMR (121 
MHz, C6D6, 25 ºC): δ 3.3 (d, JP,P = 12 Hz), −42.2 (d, JP,P = 12 Hz). 
13
C{
1
H} NMR (75 MHz, 
C6D6, 25 ºC) δ 190.7 (dd, JC,P = 17 Hz, 14 Hz, CO), 143.7 (=CH-allyl), 143.3 (pz), 138.2 (d, JC,P 
= 36 Hz, C
i
 PPh2), 133.9 (d, JC,P = 13 Hz, C
o
 PPh2), 131.3 (pz), 131.1 (d, JC,P = 5 Hz, C
p
 PPh2), 
128.0 (m, C
m
 PPh2), 110.5 (=CH2-allyl), 105.5 (pz), 49.8 (d, JC,P = 8 Hz, =CH-
2
-allyl), 35.5 (d, 
JC,P = 20 Hz, =CH2-
2
-allyl), 34.4 (br, CH2-allyl), 25.7 (br, CH2-
2
-allyl), 22.7 (br, CH2P), 15.4 
(d, JC,P = 41 Hz, PMe3).
 11
B{
1
H} NMR (96 MHz, C6D6, 25 ºC) δ −1.15 (br s). MS (MALDI-
TOF
+
): m/z (%): 615.1 (40) [M‒allyl]+. 
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[Ir(
2
-A2BPN)(CO)(Cl)(H)PPh3] (15). A suspension of 13 (0.10 g, 0.12 mmol) in diethyl 
ether (5 mL) was treated with a diethyl ether solution of HCl (176 µL, 0.67 M, 0.12 mmol), that 
produced the immediate formation of a yellowish precipitate. The solution was stirred for 30 
minutes, and then the solvent was removed to yield a pale yellow solid, that was filtered out and 
dried by vacuum. Yield: 0.10 g (98%). Anal. Calcd (%) for C41H41BClIrN2OP2 (878.22): C 
56.07, H 4.71, N 3.19; found: C 55.51, H 4.67, N 3.00. IR (CDCl3): ν(Ir–H)/cm
−1
: 2253(w), 
ν(CO)/cm−1: 2058 (s). 1H NMR (500 MHz, C6D6, 25 ºC): δ 7.84 (m, 2H, H
o
 PPh2), 7.63 (m, 6H, 
H
o
 PPh3), 7.45 (d, J = 1.9 Hz, 2H, pz), 7.37 (m, 2H, H
o‘ 
PPh2), 6.96 (m, 3H, H
m+p
 PPh2 + 9H, 
H
m+p 
PPh3), 6.86 (m, 3H, H
m‘+p‘
 PPh2), 6.06 (m, 1H) and 5.82 (m, 1H) (=CH-allyl), 5.66 (t, J = 
1.8 Hz, 1H, pz), 5.01 (m, 2H) and 4.87 (m, 2H) (=CH2-allyl), 2.52 (m, 1H, CH2-allyl), 2.09 (dd, 
J = 12.6, 6.7 Hz, 1H, CH2P), 1.94 (m, 2H CH2-allyl + 1H, CH2P), 1.53 (t, J = 9.8 Hz, 1H, CH2-
allyl), –14.47 (t, JH,P = 12.0 Hz, 1H, Ir–H). 
31
P{
1
H} NMR (202 MHz, C6D6, 25ºC): AB spin 
system δPA = –1.9, δPB = –6.7, JPA,PB = 330 Hz). 
13
C{
1
H} NMR (125 MHz, C6D6, 25 ºC): δ 167.1 
(dd, JC,P = 8, 7 Hz, CO), 144.1 (pz), 143.0 and 142.7 (=CH-allyl), 137.7 (pz), 137.2 (d, JC,P = 43 
Hz, C
i
 PPh2), 135.0 (d, JC,P = 10 Hz, C
o
 PPh3), 133.9 (dd, JC,P = 9,2 Hz) and 131.9 (d, JC,P = 9 
Hz) (C
o
 PPh2), 131.2 (d, JC,P = 2 Hz, C
p
 PPh3), 130.5 and 130.2 (d, JC,P = 2 Hz) (C
p
 PPh2), 130.0 
(d, JC,P = 49 Hz, C
i
 PPh3), 128.7 (d, JC,P = 10 Hz, C
m
 PPh3), 127.8 (m, C
m
 PPh2), 111.1 and 110.3 
(=CH2-allyl), 105.3 (pz), 34.9 (br) and 34.3 (br) (CH2-allyl), 14.4 (br, CH2P). MS (MALDI-
TOF
+
): m/z (%): 837.2 (60) [M‒allyl]+. 
 (16). A diethyl ether solution 
of HCl (0.2 mL, 0.67 M, 0.15 mmol) was added via microsyringe to a suspension of 14 (0.10 g, 
0.15 mmol) in diethyl ether (5 mL), affording instantly a yellowish precipitate. After 20 minutes 
of stirring, the supernatant liquid was removed via cannula and the solid was washed with cold 
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diethyl ether (5 mL), and then dried under vacuum. Yield: 0.1 g (94%). Anal. Calcd (%) for 
C26H35BClIrN2OP2 (692.01): C 45.13, H 5.10, N 4.05; found: C 44.67, H 5.23, N 3.92. IR 
(CDCl3): ν(CO)/cm
−1
: 2061 (s). 
1
H NMR (300 MHz, CDCl3, 25 ºC): δ 8.17 (d, J = 2.3 Hz, 1H, 
pz), 7.57 (m, 4H, H
o+o‘
 PPh2), 7.39 (m, 3H, H
m+p
 PPh2), 7.33 (m, 1H, pz), 7.15 (m, 3H, H
m‘+p‘
 
PPh2), 6.05 (m, 1H, pz), 6.04 (m, 1H, =CH-allyl), 4.83 (dd, J = 15.0, 3.0 Hz, 1H) and 4.75 (dd, J 
= 9.0, 3.0 Hz, 1H) (=CH2-allyl), 2.75 (m, 1H, Ir–CH(CH3)CH2), 1.69 (d, J = 6.0 Hz, 3H, Ir–
CH(CH3)CH2), 1.62 (m, 1H, CH2P), 1.56 (m, 2H, CH2-allyl), 1.34 (d, JH,P = 12.0 Hz, 9H, PMe3), 
1.03 (m, 1H, CH2P), 0.60 (m, 1H) and 0.11 (m, 1H) (Ir–CH(CH3)CH2). 
31
P{
1
H} NMR (121 
MHz, CDCl3, 25 ºC): δ –12.8 (d, JP,P = 22 Hz), – 46.4 (d, JP,P = 22 Hz). 
13
C{
1
H} NMR (75 MHz 
CDCl3, 25 ºC): δ 168.1 (dd, JC-P = 132, 9 Hz, CO), 143.3 (=CH-allyl), 142.2 (d, JC,P = 2 Hz, pz), 
135.4 (dd, JC,P = 40, 3 Hz, C
i
 PPh2), 134.1 (d, JC,P = 9 Hz, C
o
 PPh2), 133.5 (d, JC,P = 4 Hz, pz), 
132.7 (d, JC,P = 9 Hz, C
o‘
 PPh2), 131.5 (d, JC,P = 55 Hz, C
i‘
 PPh2), 130.3 (d, JC,P = 2 Hz) and 
129.8 (d, JC,P = 2 Hz) (C
p+p‘
 PPh2), 128.5 (d, JC,P = 9 Hz) and 127.2 (d, JC,P = 10 Hz) (C
m+m‘
 
PPh2), 110.2 (=CH2-allyl), 105.3 (pz), 37.2 (Ir–CH(CH3)CH2), 37.0 (br, Ir–CH(CH3)CH2), 33.2 
(br, CH2-allyl), 16.4 (br, CH2P), 15.2 (Ir–CH(CH3)CH2), 14.6 (d, JC,P = 41 Hz, PMe3). MS 
(MALDI-TOF
+
): m/z (%): 614.9 (20) [M‒PMe3]
+
, 586.9 (5) [M‒PMe3‒CO]
+
. 
[Ir(
3
-A2BPN)(CO)(H2C=CH2)] (17). Carbon monoxide was bubled through an orange 
solution of 3 (0.10 g, 0.16 mmol) in diethyl ether (12 mL) for 20 minutes to yield a transparent 
yellow solution. Then, the solution was exposed to an ethylene atmosphere for 26 hours. The 
solvent was then evaporated and the oily residue was washed with hexanes to yield a pale yellow 
solid. It was filtered out and dried under vacuum. Yield: 0.070 g (69%). Anal. Calcd (%) for 
C25H29BIrN2OP (607.52): C 49.43, H 4.81, N 4.61; found: C 49.52, H 4.76, N 4.51. IR (ATR): 
ν(CO)/cm−1: 2005 (s). IR (C6D6): ν(CO)/cm
−1
: 2013 (s). 
1
H NMR (300 MHz, C6D6, 25 ºC): δ 
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7.57 (m, 2H, H
o
 PPh2), 7.47 (d, J = 2.0 Hz, 1H, pz), 7.07 (m, 2H, H
m
 PPh2), 6.94 (1H, H
p
 PPh2 + 
5H, H
o’+m’+p’
 PPh2), 6.40 (m, 1H, =CH-allyl), 6.28 (d, J = 2.0 Hz, 1H, pz), 5.69 (t, J = 2.0 Hz, 
1H, pz), 5.24 (d, J = 13.8 Hz, 1H) and 5.16 (d, J = 10.2 Hz, 1H) (=CH2-allyl), 4.30 (m, 1H, =CH-
2
-allyl), 3.67 (m, 1H, =CH2-
2
-allyl), 2.73 (m, 2H) and 2.47 (m, 1H) (
2
-H2C=CH2), 2.33 (dd, J 
= 12.5, 4.5 Hz, 1H, =CH2-
2
-allyl), 2.07 (t, JH,H = 9 Hz, 1H, CH2-
2
-allyl), 1.91 (m, 2H, CH2-
allyl), 1.69 (t, JH,P = 14.6 Hz, 1H, CH2P), 1.33 (m, 1H, 
2
-H2C=CH2), 1.20 (t, JH,P = 14.6 Hz, 1H, 
CH2P), 0.86 (m, 1H, CH2-
2
-allyl). 
31
P{
1
H} NMR (121 MHz, C6D6, 25 ºC): δ – 7.0 (s). 
13
C{
1
H} 
NMR (75 MHz, C6D6, 25 ºC): δ 166.0 (d, JC,P = 6 Hz, CO), 143.1 (=CH-allyl), 138.4 (d, JC,P = 
44 Hz, C
i
 PPh2), 138.0 (d, JC,P = 43 Hz, C
i’
 PPh2), 134.2 (d, JC,P = 8 Hz, pz), 132.0 (pz), 131.6 
(m, C
o+o’ 
PPh2), 129.7 (C
p
 PPh2), 129.0 (C
m+m’+p’
 PPh2), 111.4 (=CH2-allyl), 104.8 (pz), 68.7 (d, 
JC,P = 4 Hz, =CH-
2
-allyl), 41.2 (d, JC,P = 9 Hz, =CH2-
2
-allyl), 34.6 (br, CH2-allyl), 33.8 (d, JC,P 
= 6 Hz) and 28.0 (
2
-H2C=CH2), 25.6 (br, CH2-
2
-allyl), 18.4 (br, CH2P). MS (MALDI-TOF
+
): 
m/z (%): 539.2 (40) [M–allyl–CO/C2H4]
+
.  
[Ir(
3
-A2BPN)(CO)(dmad)] (18). Solid [Ir(acac)(cod)] (0.084 g, 0.21 mmol) was added to a 
suspensión of 1 (0.101 g, 0.21 mmol) in diethyl ether. After 30 minutes of stirring, the 
suspension was filtered through a pad of celite, and then carbon monoxide was bubbled to give a 
bright yellow solution. Then MeO2CC≡CCO2Me (51 l, 0.42 mmol) was added via 
microsyringe. The resulting light yellow solution was stirred for 20 more minutes. Concentration 
to ca. 0.5 mL and addition of hexanes yielded an orange solid, which was filtered out and dried 
under vacuum. Yield: 0.06 g (41%). Anal. Calcd (%) for C29H31BIrN2O5P (721.57): C 48.27, H 
4.33, N 3.88; found: C 48.05, H 4.11, N 3.76. IR (ATR): ν(CO)/cm−1: 2032 (s), ν(C=O)/cm−1: 
1699 (s). IR (toluene): ν(CO)/cm−1: 2040 (s), ν(C=O)/cm−1: 1709 (s). 1H NMR (300 MHz, C6D6, 
25 ºC): δ 7.82 (d, J = 2.4 Hz, 1H, pz), 7.74 (m, 2H, Ho PPh2), 7.34 (d, J = 2.3 Hz, 1H, pz), 7.10 
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(m, 2H, H
m
 PPh2), 7.01 (m, 1H, H
p
 PPh2), 6.83 (m, 5H, H
o’+m’+p’
 PPh2), 6.24 (m, 1H, =CH-allyl), 
5.85 (t, J = 2.4 Hz, 1H, pz), 5.12 (m, 1H) and 5.08 (m, 1H) (=CH2-allyl), 4.36 (m, 1H, =CH-
2
-
allyl), 4.26 (m, 1H, =CH2-
2
-allyl), 3.67 (s, 3H) and 3.45 (s, 3H) (OCH3), 3.30 (m, 1H, =CH2-
2
-allyl), 2.06 (m, 1H, CH2-
2
-allyl), 1.91 (t, JH,P = 14.1 Hz, 1H, CH2P), 1.70 (m, 2H, CH2-
allyl), 0.85 (m, 1H, CH2P), 0.60 (m, 1H, CH2-
2
-allyl). 
31
P{
1
H} NMR (121 MHz, C6D6, 25 ºC): 
δ – 3.1 (s). 13C{1H} NMR (75 MHz, C6D6, 25 ºC): δ 162.7 (d, JC,P = 5 Hz, C=O), 162.1 (d, JC,P = 
6 Hz, CO), 162.0 (d, JC,P = 8 Hz, C=O), 142.6 (=CH-allyl), 138.0 (d, JC,P = 50 Hz,C
i
 PPh2), 
136.5 and 135.3 (pz), 135.1 (d, JC-P = 48 Hz, C
i
 PPh2), 131.7 (d, JC-P = 11 Hz, C
o+o’
 PPh2), 130.3 
(d, JC-P = 2 Hz) and 129.7 (d, JC-P = 2 Hz) (C
p
 PPh2), 128.8 (d, JC-P = 10 Hz) and 128.1 (d, hidden 
behind solvent signal) (C
m
 PPh2), 111.7 (=CH2-allyl), 105.0 (pz), 91.5 (d, JC,P = 7 Hz) and 86.9 
(d, JC,P = 40 Hz) (C C), 82.1 (=CH-
2
-allyl), 52.3 and 52.1 (OCH3), 48.9 (d, JC-P = 5 Hz, =CH2-
2
-allyl), 34.3 (br, CH2-allyl), 26.1 (br, CH2-
2
-allyl), 17.0 (br, CH2P). MS (MALDI-TOF
+
): m/z 
(%): 663.4 (85) [M–COOMe]+. 
[Ir(
2
-A2BPN)(CN
t
Bu)2(dmad)] (19). To a yellow solution of 5 (0.110 g, 0.149 mmol) in 
THF (8 mL), dmad (20 l, 0.164 mmol) was added dropwise via microsyringe, to give a dark 
orange solution. After one hour of stirring the solvent was evaporated to give an orange residue, 
which after treatment with hexanes yielded a creamy white solid, which was filtered out and 
dried under vacuum. Yield 0.11 g (86%). %). Anal. Calcd (%) for C38H49BIrN4O4P (859.83): 
53.08, H 5.74, N 6.52; found C 53.01, H 5.65, N 6.45 IR (ATR): ν(CN)/cm−1: 2196 (s), 2164 (s), 
ν(C=O)/cm−1: 1746 (s), 1686 (s). 1H NMR (400 MHz, C6D6, 25 ºC): δ 8.29 (m, 2H, H
o
 PPh2), 
8.17 (d, J = 1.2 Hz, 1H, pz), 7.58 (d, J  = 1.6 Hz, 1H, pz), 7.52 (m, 2H, H
o’
 PPh2), 7.33 (m, 2H, 
H
m
 PPh2), 7.11 (m, 1H, H
p
 PPh2) 7.04 (m, 3H, H
m‘+p‘
 PPh2), 6.34 (m, 1H, =CH-allyl), 5.99 (t, J = 
2 Hz, 1H, pz), 5.68 (m, 1H, =CH-allyl), 5.21 (d, J = 14.4 Hz, 1H) and 5.12 (d, J = 10.0 Hz, 1H) 
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(=CH2-allyl), 4.81 (d, J = 10.0 Hz, 1H) and 4.74 (d, J = 17.2 Hz, 1H) (=CH2-allyl), 3.58 (s, 3H) 
and 3.53 (s, 3H) (OCH3), 2.35 (m, 1H, CH2P), 2.00 (m, 3H, CH2-allyl), 1.76 (m, 1H, CH2P), 1.13 
(m, 1H, CH2-allyl), 0.86 (s, 9H) and 0.69 (s, 9H) (CN
t
Bu). 
31
P{
1
H} NMR (161 MHz, C6D6, 25 
ºC): δ – 6.4 (s). 13C{1H} NMR (100 MHz, C6D6, 25 ºC): δ 166.5 (d, JC,P = 12 Hz,) and 163.3 (d, 
JC,P = 10 Hz) (CN
t
Bu), 152.0 and 151.9 (C=O), 146.0 (pz), 144.3 and 144.1 (=CH-allyl), 143.5 
(d, JC,P = 42 Hz, C
i
 PPh2), 135.4 (d, JC,P = 13 Hz, C
o
 PPh2), 135.2 (d, JC,P = 50 Hz, C
i‘
 PPh2), 
134.7 (pz), 131.4 (d, JC,P = 9 Hz, C
o‘
 PPh2), 130.3 (d, JC,P = 2 Hz, C
p
 PPh2), 128.1 (m, 
PPh2
m+m‘+p‘
), 110.6 and 109.2 (=CH2-allyl), 105.3 (d, JC,P = 6 Hz, C C), 105.0 (pz), 101.6 (d, JC,P 
= 66 Hz, C C), 57.9 and 57.2 (CMe3), 51.8 and 51.7 (OCH3), 34.9 and 31.8 (br, CH2-allyl), 30.0 
and 29.9 (CMe3), 17.5 (br, CH2P). MS (MALDI-TOF
+
): m/z (%): 677.4 (74) [M–dmad–allyl]+. 
DFT geometry optimizations. The computational method used was density functional theory 
(DFT) with the B3LYP exchange-correlation functional,
48
 using the Gaussian 09
49
 program 
package. The basis sets used for the full optimization of the structures and for the frequency 
calculations were LanL2TZ(f)
 
effective core potential for the metal atoms, and 6-31G(d,p) for 
the remaining atoms. 
X-ray diffraction studies on 3•0.5(C6H14), 8, 11, and·18•0.5(C6H14). Selected crystallographic 
data for these complexes can be found in Table 6. Intensity measurements were collected with a 
Smart Apex diffractometer, with graphite-monochromated MoK  radiation. A semi-empirical 
absorption correction was applied to each data set, with the multi-scan
50
 methods. All non-
hydrogen atoms were refined with anisotropic displacement parameters except one disordered 
hexane solvent molecule in 18·0.5(C6H14) which was refined with isotropic displacement 
parameters and with geometrical restraints. The hydrogen atoms were placed at calculated 
positions and were refined isotropically in riding mode. The structures were solved by direct 
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methods and refined by full-matrix least-squares with the program SHELX97
51
 in the WINGX
52
 
package. 
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Table 6. Selected Crystal, Measurement, and Refinement Data for Compounds 3•0.5(C6H14), 8, 
11, and·18•0.5(C6H14). 
 3·0.5(C6H14) 8 11 18·0.5(C6H14) 
Formula C30H37BIrN2P·0.5(C6H14) C46H50B2N4O2P2Rh2 C41H40BN2OP2Rh C29H31BIrNO5P·0.5(C6H14) 
formula weight 702.68 980.28 752.41 764.62 
Colour pale-yellow yellow yellow colourless 
crystal system orthorhombic monoclinic monoclinic monoclinic 
space group Pbca P2(1)/n P2(1)/n P2(1)/c 
a[Å] 10.856(5) 11.9199(19) 11.203(2) 18.5058(18) 
b[Å] 16.608(7) 16.647(3) 24.429(4) 9.3837(9) 
c[Å] 32.292(12) 22.872(4) 13.786(2) 18.6119(18) 
[º] 90 104.359(3) 102.177(3) 90.491(2) 
V[Å
3
] 5822(4) 4396.6(12) 3688.0(10) 3231.9(5) 
Z 8 4 4 4 
F(000) 2824 2000 1552 1524 
calcd[g cm
-3
] 1.603 1.481 1.355 1.571 
 (mm
-1
) 4.667 0.866 0.584 4.222 
crystal size[mm] 0.13 × 0.05 × 0.04 0.11 x 0.05 x 0.04 0.14x0.11x0.07 0.05 x 0.04 x 0.02 
temperature [K] 100(2) 100(2) 100(2) 100(2) 
 limits [º] 27.27 26.00 26.00 25.20 
collected reflns. 33914 25837 21901 24471 
unique reflns. (Rint) 6499 (0.0982) 8645 (0.0955) 7220 (0.0546) 5818 (0.0820) 
reflns. with I>2 (I) 4686 6354 5300 4237 
parameters/restraints 344 / 0 523 / 0 433 / 0 373 / 27 
R1 (on F, I>2 (I)) 0.0483 0.0567 0.0407 0.0402 
wR2 (on F
2
, all data) 0.0898 0.1014 0.0939 0.0896 
max./min.  [e Å
-3
] 1.129 / −1.808 0.730 / −0.844 0.710 / −0.360 1.030 
goodness of fit 1.055 1.070 0.998 1.521 / −0.845 
 
Supporting Information. Full ORTEP diagrams, selected spectroscopic data, Van’t Hoff 
plotter, atomic coordinates for calculated DFT structures, complete reference 39, and a CIF file 
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giving details of the X-ray crystal structures of 3•0.5(C6H14), 8, 11, and·18•0.5(C6H14). This 
material is available free of charge via the Internet at http://pubs.acs.org. 
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